1
|
Blin J, Hochman C, Graveline N, Masson D, Baron S, Bach-Ngohou K. Estradiol Testing in the Exploration of Early Onset Puberty: Comparison of RIA and Chemiluminescence Immunoassay. Ann Lab Med 2023; 43:632-634. [PMID: 37387498 DOI: 10.3343/alm.2023.43.6.632] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 02/24/2023] [Accepted: 05/30/2023] [Indexed: 07/01/2023] Open
Affiliation(s)
- Justine Blin
- Nantes Université, CHU Nantes, Department of Biochemistry, Nantes, France
- Nantes Université, CHU Nantes, INSERM, The Enteric Nervous System in Gut and Brain Disorders, IMAD, Nantes, France
| | - Clarisse Hochman
- Nantes Université, CHU Nantes, Service d'Endocrinologie Pédiatrique, Nantes, France
| | - Nolwenn Graveline
- Nantes Université, CHU Nantes, Department of Biochemistry, Nantes, France
| | - Damien Masson
- Nantes Université, CHU Nantes, Department of Biochemistry, Nantes, France
- Nantes Université, CHU Nantes, INSERM, The Enteric Nervous System in Gut and Brain Disorders, IMAD, Nantes, France
| | - Sabine Baron
- Nantes Université, CHU Nantes, Service d'Endocrinologie Pédiatrique, Nantes, France
| | - Kalyane Bach-Ngohou
- Nantes Université, CHU Nantes, Department of Biochemistry, Nantes, France
- Nantes Université, CHU Nantes, INSERM, The Enteric Nervous System in Gut and Brain Disorders, IMAD, Nantes, France
| |
Collapse
|
2
|
Levaillant L, Bouhours-Nouet N, Illouz F, Amsellem Jager J, Bachelot A, Barat P, Baron S, Bensignor C, Brac De La Perriere A, Braik Djellas Y, Caillot M, Caldagues E, Campas MN, Caquard M, Cartault A, Cheignon J, Decrequy A, Delemer B, Dieckmann K, Donzeau A, Doye E, Fradin M, Gaudillière M, Gatelais F, Gorce M, Hazart I, Houcinat N, Houdon L, Ister-Salome M, Jozwiak L, Jeannoel P, Labarthe F, Lacombe D, Lambert AS, Lefevre C, Leheup B, Leroy C, Maisonneuve B, Marchand I, Marquant E, Muszlak M, Pantalone L, Pochelu S, Quelin C, Radet C, Renoult-Pierre P, Reynaud R, Rouleau S, Teinturier C, Thevenon J, Turlotte C, Valle A, Vierge M, Villanueva C, Ziegler A, Dieu X, Bouzamondo N, Rodien P, Prunier-Mirebeau D, Coutant R. The Severity of Congenital Hypothyroidism With Gland-In-Situ Predicts Molecular Yield by Targeted Next-Generation Sequencing. J Clin Endocrinol Metab 2023; 108:e779-e788. [PMID: 36884306 PMCID: PMC10438870 DOI: 10.1210/clinem/dgad119] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2022] [Revised: 02/07/2023] [Accepted: 02/23/2023] [Indexed: 03/09/2023]
Abstract
INTRODUCTION Congenital hypothyroidism with gland-in-situ (CH-GIS) is usually attributed to mutations in the genes involved in thyroid hormone production. The diagnostic yield of targeted next-generation sequencing (NGS) varied widely between studies. We hypothesized that the molecular yield of targeted NGS would depend on the severity of CH. METHODS Targeted NGS was performed in 103 CH-GIS patients from the French national screening program referred to the Reference Center for Rare Thyroid Diseases of Angers University Hospital. The custom targeted NGS panel contained 48 genes. Cases were classified as solved or probably solved depending on the known inheritance of the gene, the classification of the variants according to the American College of Medical Genetics and Genomics, the familial segregation, and published functional studies. Thyroid-stimulating hormone at CH screening and at diagnosis (TSHsc and TSHdg) and free T4 at diagnosis (FT4dg) were recorded. RESULTS NGS identified 95 variants in 10 genes in 73 of the 103 patients, resulting in 25 solved cases and 18 probably solved cases. They were mainly due to mutations in the TG (n = 20) and TPO (n = 15) genes. The molecular yield was, respectively, 73% and 25% if TSHsc was ≥ and < 80 mUI/L, 60% and 30% if TSHdg was ≥ and < 100 mUI/L, and 69% and 29% if FT4dg was ≤ and > 5 pmol/L. CONCLUSION NGS in patients with CH-GIS in France found a molecular explanation in 42% of the cases, increasing to 70% when TSHsc was ≥ 80 mUI/L or FT4dg was ≤ 5 pmol/L.
Collapse
Affiliation(s)
- Lucie Levaillant
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
| | - Natacha Bouhours-Nouet
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
| | - Frédéric Illouz
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
- Department of Endocrinology, Diabetes and Nutrition, University Hospital of Angers, 49000 Angers, France
| | - Jessica Amsellem Jager
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
| | - Anne Bachelot
- Department of Endocrinology and Reproductive Medicine, Hôpital Pitié-Salpêtrière, ICAN, 75651 Paris, France
| | - Pascal Barat
- Pediatric Endocrinology, CHU de Bordeaux, 33000 Bordeaux, France
| | - Sabine Baron
- Pediatrics Department, CHU Nantes, 44000 Nantes, France
| | | | - Aude Brac De La Perriere
- Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Service d'Endocrinologie Pédiatrique, 69677 Bron, France
| | - Yasmine Braik Djellas
- Department of Endocrinology and Reproductive Medicine, Hôpital Pitié-Salpêtrière, ICAN, 75651 Paris, France
| | - Morgane Caillot
- Pediatrics Department, CH de Martigues, 13500 Martigues, France
| | | | | | | | - Audrey Cartault
- Endocrine, Genetics, Bone Diseases, and Paediatric Gynecology Unit, Children's Hospital, CHU Toulouse, 31059 Toulouse, France
| | - Julie Cheignon
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
| | - Anne Decrequy
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
| | - Brigitte Delemer
- Department of Endocrinology, Diabetes and Nutrition, CHU de Reims-Hôpital Robert-Debré, 51100 Reims, France
| | | | - Aurélie Donzeau
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
| | | | - Mélanie Fradin
- Service de Génétique, CLAD Ouest, CHU Rennes, 35200 Rennes, France
| | - Mélanie Gaudillière
- Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Service d'Endocrinologie Pédiatrique, 69677 Bron, France
| | | | - Magali Gorce
- Service de Génétique, 49000 Angers Cedex 9, France
| | | | - Nada Houcinat
- CHU Dijon, Centre de référence maladies rares Anomalies du Développement et Syndromes Malformatifs, Centre de Génétique, FHU TRANSLAD, CHU Dijon Bourgogne 21000, France
| | - Laure Houdon
- Pediatric Diabetology, University Hospital, St Pierre de la Reunion 97410, France
| | | | - Lucie Jozwiak
- Pediatrics Department, CH de Roubaix, 59100 Roubaix, France
| | | | - Francois Labarthe
- Reference Center for Inborn Errors of Metabolism, Tours University Hospital, 37044 Tours, France
| | - Didier Lacombe
- Department of Medical Genetics, CHU Bordeaux INSERM U1211, Université de Bordeaux, 33076 Bordeaux, France
| | - Anne-Sophie Lambert
- AP-HP, Bicêtre Paris Saclay Hospital, DMU SEA, Endocrinology and Diabetes for Children, Le Kremlin Bicêtre 94270, France
| | - Christine Lefevre
- Pediatric Endocrinology, Jeanne de Flandre Hospital, 59037 Lille, France
| | - Bruno Leheup
- Service de Génétique clinique, Höpital Brabois, Centre Hospitalier Universitaire de Nancy, Nancy, Lorraine 54500, France
| | - Clara Leroy
- Service d'Endocrinologie et Maladies Métaboliques, Centre Hospitalier Régional Universitaire de Lille, Hôpital Huriez, 59037 Lille, France
| | | | - Isis Marchand
- Pediatrics Department, CHI de Créteil, 94010 Créteil, France
| | - Emeline Marquant
- Assistance-Publique des Hôpitaux de Marseille, Department of Pediatrics, Hôpital de la Timone Enfants, 13005 Marseille, France
| | | | | | - Sandra Pochelu
- Pediatric Endocrinology, CHU de Bordeaux, 33000 Bordeaux, France
| | - Chloé Quelin
- Service de Génétique, CLAD Ouest, CHU Rennes, 35200 Rennes, France
| | | | - Peggy Renoult-Pierre
- Service de Médecine Interne, Unité d'Endocrinologie Diabétologie et Nutrition, Centre Hospitalier Universitaire et Faculté de Médecine, Université de Tours, 37044 Tours, France
| | - Rachel Reynaud
- Assistance-Publique des Hôpitaux de Marseille, Department of Pediatrics, Hôpital de la Timone Enfants, 13005 Marseille, France
| | - Stéphanie Rouleau
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
| | - Cécile Teinturier
- AP-HP, Bicêtre Paris Saclay Hospital, DMU SEA, Endocrinology and Diabetes for Children, Le Kremlin Bicêtre 94270, France
| | - Julien Thevenon
- Inserm UMR 1231 GAD Team, Genetics of Developmental Anomalies, and FHU-TRANSLAD, CHU/Université de Bourgogne-Franche Comté, 21000 Dijon, France
| | | | - Aline Valle
- Pediatrics Department, CH de Douai, 59187 Douai, France
| | - Melody Vierge
- Assistance-Publique des Hôpitaux de Marseille, Department of Pediatrics, Hôpital de la Timone Enfants, 13005 Marseille, France
| | - Carine Villanueva
- Hospices Civils de Lyon, Hôpital Femme Mère Enfant, Service d'Endocrinologie Pédiatrique, 69677 Bron, France
| | | | - Xavier Dieu
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
- Biochemistry and Molecular Biology Laboratory, University Hospital of Angers, 49000 Angers, France
| | - Nathalie Bouzamondo
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
- Biochemistry and Molecular Biology Laboratory, University Hospital of Angers, 49000 Angers, France
| | - Patrice Rodien
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
- Department of Endocrinology, Diabetes and Nutrition, University Hospital of Angers, 49000 Angers, France
| | - Delphine Prunier-Mirebeau
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
- Biochemistry and Molecular Biology Laboratory, University Hospital of Angers, 49000 Angers, France
| | - Régis Coutant
- Department of Pediatric Endocrinology and Diabetology, University Hospital of Angers, 49000 Angers, France
- Reference Center for Rare Diseases of Thyroid and Hormone Receptivity, University Hospital of Angers, 49000 Angers, France
| |
Collapse
|
3
|
Injeyan M, Baron S, Lauzier B, Gaillard‐Le Roux B, Denis M. Hyperglycaemic hyperosmolar state and cerebral thrombophlebitis in paediatrics: A case report. Endocrinol Diabetes Metab 2023; 6:e389. [PMID: 36722309 PMCID: PMC10000624 DOI: 10.1002/edm2.389] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2022] [Revised: 10/12/2022] [Accepted: 10/16/2022] [Indexed: 02/02/2023] Open
Abstract
INTRODUCTION Hyperglycaemic hyperosmolar state (HHS) is a known complication of type 2 diabetes mellitus; however, carbonated carbohydrate fluid intake may precipitate a more severe presentation of type 1 diabetes mellitus with hyperosmolar state. The management of these patients is not easy and can lead to severe complications such as cerebral venous thrombosis. METHODS We present the case of a 21-month-old boy admitted for consciousness disorders revealing a hyperglycaemic hyperosmolar state on a new-onset type 1 diabetes and who developed cerebral venous thrombosis. RESULTS AND CONCLUSION Emergency physicians should be aware of HHS in order to start the appropriate treatment as early as possible and to monitor the potential associated acute complications. This case highlights the importance of decreasing very gradually the osmolarity in order to avoid cerebral complications. Cerebral venous thrombosis in HHS paediatric patients is rarely described, and it is important to recognize that not all episodes of acute neurological deterioration in HHS or diabetic ketoacidosis are caused by cerebral oedema.
Collapse
Affiliation(s)
- Maud Injeyan
- Department of PediatricsCHU de NantesNantesFrance
| | - Sabine Baron
- Department of PediatricsCHU de NantesNantesFrance
- Department of Pediatric EndocrinologyCHU de NantesNantesFrance
| | - Benjamin Lauzier
- Pediatric Intensive Care UnitCHU de NantesNantesFrance
- Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thoraxNantesFrance
| | | | - Manon Denis
- Pediatric Intensive Care UnitCHU de NantesNantesFrance
- Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thoraxNantesFrance
| |
Collapse
|
4
|
Bonnet E, Winter M, Mallet D, Plotton I, Bouvattier C, Cartigny M, Martinerie L, Polak M, Bachelot A, Huet F, Baron S, Houang M, Soskin S, Lienhardt A, Bertherat J, Amouroux C, Bouty A, Duranteau L, Besson R, El Ghoneimi A, Samara-Boustani D, Becmeur F, Kalfa N, Paris F, Medjkane F, Brac de la Perrière A, Bretones P, Lejeune H, Nicolino M, Mouriquand P, Gorduza DB, Gay CL. Changes in the clinical management of 5α-reductase type 2 and 17β-hydroxysteroid dehydrogenase type 3 deficiencies in France. Endocr Connect 2023; 12:EC-22-0227. [PMID: 36606580 PMCID: PMC9986397 DOI: 10.1530/ec-22-0227] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/18/2022] [Accepted: 01/05/2023] [Indexed: 01/07/2023]
Abstract
OBJECTIVES To examine the changes in diagnostic practices and clinical management of patients with 5α-reductase type 2 (SRD5A2) or 17β-hydroxysteroid dehydrogenase type 3 (HSD17B3) deficiency since molecular diagnoses became available. METHODS Clinical, laboratory, and therapeutic data were retrieved from the medical records of 52 patients with a molecular diagnosis of SRD5A2 (n = 31) or HSD17B3 (n = 21) deficiency. Temporal trends regarding age at assessment and initial sex assignment over 1994-2020 were qualitatively analyzed. Age at molecular diagnosis was compared between two subgroups of patients according to their year of birth. RESULTS Fifty-eight percent (n = 30) patients were diagnosed during the perinatal period, 33% (n = 17) during infancy, and 9% (n = 5) during adolescence or adulthood. Over the studied period, the patients' age at initial assessment and diagnosis frankly decreased. The median (range) age at diagnostic confirmation was 10.5 (0-53.2) years for patients born before 2007 and 0.4 (0-9.3) years for those born in 2007 or later (P = 0.029). Genetic testing identified 27 different variants for the SRD5A2 gene (30% novel, n = 8) and 18 for the HSD17B3 gene (44% novel, n = 8). Before 2002, most patients were initially assigned as females (95%, n = 19), but this proportion dropped for those born later (44%, n = 14; P < 0.001). The influence of initial genital appearance on these decisions seemingly decreased in the most recent years. Therapeutic interventions differed according to the sex of rearing. Ten percent (n = 2) patients requested female-to-male reassignment during adulthood. CONCLUSION This study showed, over the past two decades, a clear trend toward earlier diagnosis and assignment of affected newborns as males.
Collapse
Affiliation(s)
- Estelle Bonnet
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service d’endocrinologie pédiatrique, Bron, France
| | - Mathias Winter
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de psychopathologie du développement, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
- Correspondence should be addressed to A Brac de la Perrière or M Winter: or
| | - Delphine Mallet
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Centre de biologie et pathologie Est, Service d’hormonologie, d’endocrinologie moléculaire et des maladies rares, Bron, France
| | - Ingrid Plotton
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service Endocrinologie Moléculaire et Maladies Rares, Bron, France
| | - Claire Bouvattier
- Centre Hospitalier Universitaire AP-HP, Hôpital Bicêtre, Service d’endocrinologie pédiatrique Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN Université Paris Saclay, Le Kremlin-Bicêtre, France
| | - Maryse Cartigny
- Centre Hospitalier Régional Universitaire Lille, Hôpital Jeanne de Flandre, Unité d’Endocrinologie pédiatrique Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Lille, France
| | - Laetiti Martinerie
- Centre Hospitalier Universitaire AP-HP, Hôpital Robert Debré, Service d’Endocrinologie pédiatrique Centre de Référence des Maladies Rares Endocriniennes de la Croissance et du Développement – CRMERC Université de Paris, Paris, France
| | - Michel Polak
- Centre Hospitalier Universitaire AP-HP, Hôpital universitaire Necker Enfants malades, Endocrinologie gynécologie diabétologie pédiatriques Centre de référence des maladies endocriniennes rares de la croissance et du développement Inserm U1016, institut Imagine, Paris, France
| | - Anne Bachelot
- Centre Hospitalier Universitaire AP-HP, Hôpital Pitié Salpêtrière, Department of Endocrinology and Reproductive Medicine Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement Centre de Référence des pathologies gynécologiques rares IE3M, Paris, France
| | - Frédéric Huet
- Centre Hospitalier Universitaire Dijon-Bourgogne, Hôpital d’Enfants, Service de Pédiatrie Multidisciplinaire, Dijon, France
| | - Sabine Baron
- Centre Hospitalier universitaire de Nantes, Hôpital Mère-Enfant, Service de Pédiatrie, Nantes, France
| | - Muriel Houang
- Centre Hospitalier Universitaire AP-HP, Hôpital Armand Trousseau, Service d'Explorations Fonctionnelles Endocriniennes, Paris, France
| | - Sylvie Soskin
- Hôpitaux Universitaires de Strasbourg, CHU Hautepierre, Service de Pédiatrie 1, Strasbourg, France
| | - Anne Lienhardt
- Centre hospitalier universitaire Limoges, Hôpital de la Mère et de l’enfant, Service de Pédiatrie, Limoges, France
| | - Jérôme Bertherat
- Groupement Hospitalier Universitaire de Paris, AP-HP, Hôpital Cochin, Service d'Endocrinologie, Paris, France
| | - Cyril Amouroux
- Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Service de Néphrologie et Endocrinologie Pédiatrique Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Montpellier, France
| | - Aurore Bouty
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
| | - Lise Duranteau
- AP-HP, Hôpital Bicêtre, Unité de gynécologie de l’adolescente Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN Université Paris Saclay, Le Kremlin-Bicêtre, France
| | - Rémi Besson
- Centre Hospitalier Régional Universitaire Lille, Hôpital Jeanne de Flandre, Service de chirurgie pédiatrique Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Lille, France
| | - Alaa El Ghoneimi
- Centre Hospitalier Universitaire AP-HP Robert Debré, Service de Chirurgie Viscérale et Urologie pédiatrique Centre de Référence des Maladies Endocriniennes de la croissance et du développement – CRMERC Université de Paris, Paris, France
| | - Dinane Samara-Boustani
- Centre Hospitalier Universitaire AP-HP, Hôpital Necker Enfants malades, Endocrinologie gynécologie diabétologie pédiatriques Centre de référence des maladies endocriniennes rares de la croissance et du développement, Paris, France
| | - François Becmeur
- Hospitaux Universitaires de Strasbourg, CHU Hautepierre, Service de chirurgie pédiatrique, Strasbourg, France
| | - Nicolas Kalfa
- Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Service de Chirurgie Viscérale et Urologie Pédiatrique Centre National de Référence Maladies Rares du Développement Génital Constitutif Sud Institut Debrest de Santé Publique IDESP, UMR INSERM, Université de Montpellier, Montpellier, France
| | - Françoise Paris
- Centre Hospitalier Universitaire de Montpellier, Hôpital Lapeyronie, Service de Néphrologie et Endocrinologie Pédiatrique Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Montpellier, France
| | - François Medjkane
- Centre Hospitalier Régional Universitaire Lille, Hôpital Jeanne de Flandre, Service de psychiatrie de l’enfant et de l’adolescent Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Lille, France
| | - Aude Brac de la Perrière
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Groupement Hospitalier Est, Service d’endocrinologie, Bron, France
- Correspondence should be addressed to A Brac de la Perrière or M Winter: or
| | - Patricia Bretones
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service d’endocrinologie pédiatrique, Bron, France
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
| | - Hervé Lejeune
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de médecine de la reproduction, Bron, France
- Université Claude Bernard, Lyon, France
| | - Marc Nicolino
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service d’endocrinologie pédiatrique, Bron, France
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Université Claude Bernard, Lyon, France
| | - Pierre Mouriquand
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
- Université Claude Bernard, Lyon, France
| | - Daniela-Brindusa Gorduza
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service de chirurgie Uro-viscérale et de Transplantation de l’Enfant, Bron, France
| | - Claire-Lise Gay
- Hospices Civils de Lyon, Hôpital Femme-Mère-Enfant, Service d’endocrinologie pédiatrique, Bron, France
- Centre National de Référence Maladies Rares du développement génital du fœtus à l’adulte DEV-GEN, Hospices Civils de Lyon, Bron, France
| |
Collapse
|
5
|
Falcinelli M, Al-Hity G, Baron S, Mampay M, Allen MC, Samuels M, Jones W, Cilibrasi C, Flaherty RL, Giamas G, Thaker PH, Flint MS. Propranolol reduces IFN-γ driven PD-L1 immunosuppression and improves anti-tumour immunity in ovarian cancer. Brain Behav Immun 2023; 110:1-12. [PMID: 36796704 DOI: 10.1016/j.bbi.2023.02.011] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Revised: 02/10/2023] [Accepted: 02/11/2023] [Indexed: 02/16/2023] Open
Abstract
The immune system plays an important role in controlling epithelial ovarian cancer (EOC). EOC is considered to be a "cold tumour," a tumour that has not triggered a strong response by the immune system. However, tumour infiltrating lymphocytes (TILs) and the expression of programmed cell death ligand (PD-L1) are used as prognostic indicators in EOC. Immunotherapy such as PD-(L)1 inhibitors have shown limited benefit in EOC. Since the immune system is affected by behavioural stress and the beta-adrenergic signalling pathway, this study aimed to explore the impact of propranolol (PRO), a beta-blocker, on anti-tumour immunity in both in vitro and in vivo EOC models. Noradrenaline (NA), an adrenergic agonist, did not directly regulate PD-L1 expression but PD-L1 was significantly upregulated by IFN-γ in EOC cell lines. IFN-γ also increased PD-L1 on extracellular vesicles (EVs) released by ID8 cells. PRO significantly decreased IFN-γ levels in primary immune cells activated ex vivo and showed increased viability of the CD8+ cell population in an EV-immune cell co-incubation. In addition, PRO reverted PD-L1 upregulation and significantly decreased IL-10 levels in an immune-cancer cell co-culture. Chronic behavioural stress increased metastasis in mice while PRO monotherapy and the combo of PRO and PD-(L)1 inhibitor significantly decreased stress-induced metastasis. The combined therapy also reduced tumour weight compared to the cancer control group and induced anti-tumour T-cell responses with significant CD8 expression in tumour tissues. In conclusion, PRO showed a modulation of the cancer immune response by decreasing IFN-γ production and, in turn, IFN-γ-mediated PD-L1 overexpression. The combined therapy of PRO and PD-(L)1 inhibitor decreased metastasis and improved anti-tumour immunity offering a promising new therapy.
Collapse
Affiliation(s)
- M Falcinelli
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK
| | - G Al-Hity
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK
| | - S Baron
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK
| | - M Mampay
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK
| | - M C Allen
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK
| | - M Samuels
- University of Sussex, Department for Biochemistry and Biomedicine, Falmer, Brighton BN1 9QG, UK
| | - W Jones
- University of Sussex, Department for Biochemistry and Biomedicine, Falmer, Brighton BN1 9QG, UK
| | - C Cilibrasi
- University of Sussex, Department for Biochemistry and Biomedicine, Falmer, Brighton BN1 9QG, UK
| | - Renee L Flaherty
- The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, SW3 6JG London, UK
| | - G Giamas
- University of Sussex, Department for Biochemistry and Biomedicine, Falmer, Brighton BN1 9QG, UK
| | - P H Thaker
- Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Washington University School of Medicine, St Louis, MO 63110, United States
| | - M S Flint
- University of Brighton, School of Pharmacy & Biosciences, Brighton BN2 4GJ, UK.
| |
Collapse
|
6
|
Goldsworthy S, Baron S, Muir N, Button D, Goodhand K, Fasken L. International research collaborations: Lessons learned and practical tips. Nurse Educ Today 2022; 119:105591. [PMID: 36257079 DOI: 10.1016/j.nedt.2022.105591] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/30/2022] [Revised: 09/26/2022] [Accepted: 10/05/2022] [Indexed: 06/16/2023]
Affiliation(s)
| | - S Baron
- Bournemouth University, Bournemouth, England, United Kingdom of Great Britain and Northern Ireland
| | - N Muir
- Chichester University, Chichester, England, United Kingdom of Great Britain and Northern Ireland
| | - D Button
- Flinders University, Adelaide, Australia
| | - K Goodhand
- Robert Gordon University, Aberdeen, Scotland, United Kingdom of Great Britain and Northern Ireland
| | - L Fasken
- Nipissing University, North Bay, Canada
| |
Collapse
|
7
|
Gunn V, O'Campo P, Buhariwala P, Muntaner C, Lewchuk W, Baron S, Bodin T. Health services gaps experienced by non-standard workers in Ontario, Canada: Policy implications. Eur J Public Health 2022. [PMCID: PMC9594204 DOI: 10.1093/eurpub/ckac131.279] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
Background While the Canadian universal health system provides access to basic services, key health benefits are employer dependent. Given that non-standard workers (NSWs) only rarely have access to such benefits they have increased vulnerability to the many insecurities derived from their precarious employment, as clearly seen during the pandemic. The growing problem of non-standard work and workers’ heightened risk for health status deterioration, followed by a possible accentuation of health inequities, is a population health concern. This study summarizes several health services gaps experienced by NSWs and discusses policy implications and possible solutions. Methods From January to July 2021, we conducted semi-structured interviews with a purposive sample of 40 NSWs in Ontario, Canada, part of a larger mixed-methods six-country study, including three European countries. The target population consisted of workers aged 25 to 55 who, at the time of the survey, were in non-standard employment or lost their job due to the COVID-19 pandemic. Results Our findings highlight complex physical and mental health problems and an overall high burden of disease facing NSWs during the pandemic as linked to a combination of constant stress and worry arising from their employment insecurity, the limited and inconsistent income available to cover their basic needs, and the inadequate and unsafe working conditions they are afraid to challenge. Despite their increased health needs, given that specialized health services are not available to them for free they face financial barriers in accessing much needed health services that could help improve their health status and as a result, delay seeking care or avoid it altogether. Conclusions Sustainable multi sectorial policy solutions are needed including the adoption of relevant labour market legislation and increases in social and health expenditures along with re-adjustments in the ways in which health services are delivered. Key messages • During the pandemic non-standard workers in Ontario, Canada experienced complex health problems and, despite increased health needs, encountered barriers in accessing specialized health services. • The growing problem of non-standard work and workers’ heightened risk for health status deterioration, followed by a possible accentuation of health inequities, is a population health concern.
Collapse
Affiliation(s)
- V Gunn
- Unit of Occupational Medicine, Institute of Environmental Medicine KI , Stockholm, Sweden
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute , Toronto, Canada
- Lawrence S. Bloomberg Faculty of Nursing, Dalla Lana School of Public Health , Toronto, Canada
| | - P O'Campo
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute , Toronto, Canada
- Dalla Lana School of Public Health , Toronto, Canada
| | - P Buhariwala
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute , Toronto, Canada
| | - C Muntaner
- Lawrence S. Bloomberg Faculty of Nursing, Dalla Lana School of Public Health , Toronto, Canada
- Dalla Lana School of Public Health , Toronto, Canada
- Department of Mental Health, The Johns Hopkins University Bloomberg School of Public Health , Baltimore, USA
| | - W Lewchuk
- School of Labour Studies & Department of Economics, McMaster University , Hamilton, Canada
| | - S Baron
- Community Health and Social Sciences, Graduate School of Public Health and Health Policy, City University NY , New York, USA
| | - T Bodin
- Unit of Occupational Medicine, Institute of Environmental Medicine KI , Stockholm, Sweden
- Center for Occupational and Environmental Medicine, Stockholm Region , Stockholm, Sweden
| |
Collapse
|
8
|
Cuervo I, Ahonen EQ, Vignola EF, Davis L, Baron S. Hustle: Experiences of making work ‘work’ for non-standard and precariously employed workers in NYC. Eur J Public Health 2022. [PMCID: PMC9593792 DOI: 10.1093/eurpub/ckac130.124] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022] Open
Abstract
Background Precarious and non-standard employment (NSE) has negative implications for workers’ health. As part of a six-country comparative mixed methods case study, this research explores US-based workers’ experiences in NSE and its influences on their health and well-being in a context of weak labor regulations and social welfare programs. Methods To understand US policy context, we analyzed country-level labor regulatory and social protection frameworks using 2019 Organization for Economic Cooperation and Development data. To understand workers’ experiences, we conducted in-depth interviews with NSE workers in various occupations in New York City (N = 40) between January and May 2021. We recruited and screened eligibility via Facebook advertisements and an online questionnaire, respectively. We used deductive and inductive thematic analysis for interview data. Results With heavy reliance on market competition in the US, minimal state regulation and flexible labor markets create less secure employment along with limited government-funded social supports. Workers’ experiences center on the Hustle, i.e., figuring out how to make NSE work for them and their families. They lack healthcare coverage and have low expectations of other supportive employment and social protections (e.g., paid leave). While NSE payoffs (e.g., perceived flexibility) were common for most, almost all experience NSE tradeoffs (e.g., job insecurity and instability) that create stress and overwork, negatively implicating overall health and well-being. These impacts differ by access to resources associated with social location (e.g., immigration status). COVID-19 exacerbated these experiences. Discussion Low expectations of supportive policies of US workers in NSE are linked to the individualized hustle, as they attempt to counter NSE tradeoffs often relying on family to fill those gaps. Over-reliance on privatization for social supports such as healthcare coverage can be detrimental to workers’ health. Key messages
Collapse
Affiliation(s)
- I Cuervo
- Commoner Center Health and Environment, Queens College, City University of New York , Flushing, USA
| | - EQ Ahonen
- Occupational and Environmental Health, University of Utah School of Medicine, Salt Lake City, USA
| | - EF Vignola
- Community Health and Social Sciences, CUNY Graduate School of Public Health , New York, USA
| | | | - S Baron
- Commoner Center Health and Environment, Queens College, City University of New York , Flushing, USA
| |
Collapse
|
9
|
Kvart S, Cuervo I, Gunn V, Baron S, Bodin T. Labor and social protection gaps impacting health of non-standard workers: An international study. Eur J Public Health 2022. [DOI: 10.1093/eurpub/ckac129.437] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Labor regulations and social protection structures are intended to protect workers, but the needs of those in precarious and non-standard employment (NSE) are often missed, which may negatively impact health and well-being. The aim of this research is to document how workers in NSE in six countries - Belgium, Canada, Chile, Spain, Sweden, and the US - with varying policy contexts experience aspects of employment that are linked to health.
Methods
We employed a mixed methods approach for this study. To understand policy contexts, we analyzed country-level labor regulatory and social protection frameworks using 2019 Organization for Economic Cooperation and Development data. To understand the experiences of workers in NSE, we conducted 250 in-depth interviews with workers at different levels of employment precariousness between January and June 2021.
Results
Overall, European countries have the most social expenditures and North American countries have the weakest labor market regulations. In all these varying contexts, workers in NSE reported multiple unmet needs, e.g., inadequate paid sick and parental leave and unemployment compensation. These unmet needs occur due to various barriers, including poor enforcement, legal loopholes, or required minimum employment time. Workers’ living accommodations are also affected, as home financing or rental contracts are dependent on permanent employment. In response, they tended to rely disproportionately on individual or family resources for financial and social support rather than on government or employer resources.
Conclusions
Findings suggested that diverse labor regulatory and welfare regime contexts are unsupportive of workers in NSE due to multiple gaps in policies essential to public health. The shifting of responsibility for key employment and social supports to individuals and their families is likely to increase health inequities for workers in NSE.
Key messages
• Our study documents multiple policy gaps affecting key employment-related social determinants of health among workers in NSE.
• This occurred across diverse labor and social structure contexts in six countries.
Collapse
Affiliation(s)
- S Kvart
- Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet , Stockholm, Sweden
| | - I Cuervo
- Commoner Center Health and Environment, Queens College, City University of New York , Flushing, USA
| | - V Gunn
- Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet , Stockholm, Sweden
- Lawrence S. Bloomberg Faculty of Nursing, University of Toronto , Toronto, Canada
- MAP Centre for Urban Health Solutions, Li Ka Shing Knowledge Institute , Toronto, Canada
| | - S Baron
- Commoner Center Health and Environment, Queens College, City University of New York , Flushing, USA
| | - T Bodin
- Unit of Occupational Medicine, Institute of Environmental Medicine, Karolinska Institutet , Stockholm, Sweden
- Center for Occupational and Environmental Medicine, Stockholm Region , Stockholm, Sweden
| | | |
Collapse
|
10
|
Bosmans K, Vignola E, López VÁ, Pérez MJ, Baron S, Bodin T. The various insecurities experienced among non-standard workers across different policy-contexts. Eur J Public Health 2022. [PMCID: PMC9593669 DOI: 10.1093/eurpub/ckac130.126] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Background Over the last decades, the prevalence of non-standard employment (NSE) has increased in many countries, with negative implications for worker health and well-being. Research at the micro level, mostly quantitative, has linked NSE with poor health through insecurity. Macro-level studies investigating whether political economic factors buffer the harms of NSE have generated mixed results. This study describes how various types of insecurity are experienced by workers in NSE, in general and during COVID-19, and how this influences their health and well-being, in six countries with different welfare states: Belgium, Canada, Chile, Spain, Sweden and the United States. Methods In-depth interviews with 250 workers in NSE were analysed using a multiple-case study approach and using the welfare state typology as a macro-level framework. Results Despite differences in welfare states, workers in all six countries experienced multiple forms of insecurity as well as relational tension with employers or clients, with clear negative effects on their well-being, in ways that were shaped by broader social inequalities (e.g., related to gender, age, and access to family support). Simultaneously, differences in welfare states were reflected in the level of workers’ exclusion from social protections, the temporality of difficulties they faced in planning their lives (e.g., threats to daily survival or to longer-term life planning), and their ability to derive control from NSE despite the insecurity it created. Workers in less generous welfare states experienced heightened insecurity and greater stress from the COVID-19, but the severity of the health and economic crisis was felt by workers in all study countries. Conclusions This study sheds light on the ways that welfare regimes can support - or fail to support - workers in NSE, and suggests the need in all six countries for stronger state responses to NSE, a pressing social determinant of health. Key messages
Collapse
Affiliation(s)
- K Bosmans
- Interface Demography, Vrije Universiteit Brussel , Brussels, Belgium
| | - E Vignola
- Community Health and Social Sciences, City University of New York School of Public Health, New York City, USA
| | - V Álvarez López
- School of Sociology, University of Valparaíso , Valparaíso, Chile
| | - M Julià Pérez
- SDHEd, Hospital del Mar Medical Research Institute , Barcelona, Spain
- ESIMar, Parc de Salut Mar , Barcelona, Spain
- GREDS-EMCONET, Universitat Pompeu Fabra , Barcelona, Spain
| | - S Baron
- Commoner Center Health and the Environment, Queens College, City University of New York, New York City, USA
| | - T Bodin
- Unit Occupational Medicine, Karolinska Institutet , Stockholm, Sweden
- Centre for Occupational and Environmental Medicine, Stockholm Region , Stockholm, Sweden
| | | |
Collapse
|
11
|
Lugat A, Drui D, Baron S, Thebaud E, Supiot S, Jouglar E, Doré M. Effets secondaires endocriniens de la radiothérapie : diagnostic, prévention et traitements. Cancer Radiother 2022; 26:1078-1089. [DOI: 10.1016/j.canrad.2021.12.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2021] [Revised: 11/19/2021] [Accepted: 12/24/2021] [Indexed: 11/30/2022]
|
12
|
Bui TV, Prot-Bertoye C, Ayari H, Baron S, Bertocchio JP, Bureau C, Davis P, Blanchard A, Houillier P, Prie D, Lillo-Le Louet A, Courbebaisse M. Safety of Inulin and Sinistrin: Combining Several Sources for Pharmacovigilance Purposes. Front Pharmacol 2021; 12:725417. [PMID: 34867328 PMCID: PMC8637630 DOI: 10.3389/fphar.2021.725417] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/15/2021] [Accepted: 10/26/2021] [Indexed: 11/13/2022] Open
Abstract
Introduction: Inulin and its analog sinistrin are fructose polymers used in the food and pharmaceutical industries. In 2018, The French National Agency for the Safety of Medicines and Health Products (ANSM) decided to withdraw products containing sinistrin and inulin due to several reports of serious hypersensitivity reactions, including a fatal outcome. Objective: To assess the safety of inulin and sinistrin use in France. Methods: We searched multiple sources to identify adverse reactions (ARs) to inulin or sinistrin: first, classical pharmacovigilance databases including the French Pharmacovigilance (FPVD) and the WHO Database (VigiBase); second, data from a clinical trial, MultiGFR; third, data regarding current use in an hospital. All potential ARs to inulin or sinistrin were analyzed with a focus on hypersensitivity reactions and relationships to batches of sinistrin. Results: From 1991 to 2018, 134 ARs to inulin or sinistrin were registered in the FPVD or VigiBase. Sixty-three cases (47%) were classified as serious, and 129 cases (96%) were hypersensitivity reactions. We found an association between a batch of sinistrin and the occurrence of hypersensitivity reactions. During the MultiGFR clinical trial, 7 patients (7/163 participants) had an Adverse reaction; of these, 4 were hypersensitivity reactions including one case of grade 4 anaphylactic shock. In the hospital, no ARs were observed. In the literature, ARs to inulin and sinistrin are very rarely reported and mostly benign. Conclusion: Most ARs to inulin and sinistrin are hypersensitivity reactions that appear to be associated with sinistrin batches.
Collapse
Affiliation(s)
- T-V Bui
- Assistance Publique-Hôpitaux de Paris, Centre Régional de Pharmacovigilance, Hôpital Européen Georges Pompidou, Paris, France
| | - C Prot-Bertoye
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.,CNRS ERL 8228-Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - H Ayari
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - S Baron
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.,CNRS ERL 8228-Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - J-P Bertocchio
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - C Bureau
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France
| | - P Davis
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France
| | - A Blanchard
- Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.,CNRS ERL 8228-Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France.,Assistance Publique Hôpitaux des Hôpitaux de Paris, Hôpital Européen Georges-Pompidou, Centre d'investigation Clinique, Paris, France.,Institut National de la Santé et de la Recherche Médicale, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - P Houillier
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris, France.,CNRS ERL 8228-Laboratoire de Physiologie Rénale et Tubulopathies, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France
| | - D Prie
- Faculté de Médecine, Université de Paris, Paris, France.,Service des Explorations Fonctionnelles, Hôpital Necker, APHP Centre-Université de Paris, Paris, France.,INEM Unité Inserm U1151, Paris, France
| | - A Lillo-Le Louet
- Assistance Publique-Hôpitaux de Paris, Centre Régional de Pharmacovigilance, Hôpital Européen Georges Pompidou, Paris, France
| | - M Courbebaisse
- Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris, France.,Centre de Référence des Maladies Rénales Héréditaires de l'Enfant et de l'Adulte (MARHEA), Paris, France.,Centre de Référence des Maladies Rares du Calcium et du Phosphate, Paris, France.,Faculté de Médecine, Université de Paris, Paris, France.,INEM Unité Inserm U1151, Paris, France
| |
Collapse
|
13
|
Bouchareb E, Bunay J, Gonthier C, Lobaccaro JM, Trousson A, Degoul F, De Joussineau C, Morel L, Kocer A, Baron S. Mechanisms of epithelial mesenchymal transition by TGF-ß and LXRs in metastatic prostate cancer. EUR UROL SUPPL 2021. [DOI: 10.1016/s2666-1683(21)01215-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
14
|
Cohen R, Bouderlique E, Bureau C, Baron S, Larceneux F, Seervai R, Blanchard A, Houillier P, Vrigneaud L, Bertocchio JP. Waterline : le test de charge hydrique identifie un groupe de patients avec Syndrome d’Anti-Diurèse Inappropriée (SIAD) avec une natrémie > 135 mM. Nephrol Ther 2021. [DOI: 10.1016/j.nephro.2021.07.215] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
15
|
Shahid A, Shepherd K, Shivamurthy V, Lebas E, Calonje E, Baron S, Abdelrahman W. Progressive atrophic indurated plaques in a 16-year-old boy. Clin Exp Dermatol 2021; 46:1146-1149. [PMID: 34042224 DOI: 10.1111/ced.14668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Revised: 03/28/2021] [Accepted: 03/30/2021] [Indexed: 12/01/2022]
Affiliation(s)
- A Shahid
- Departments of, Dermatology, St John's Institute of Dermatology, London, UK
| | - K Shepherd
- Department of Rheumatology, Evelina London Children's Hospital, London, UK
| | - V Shivamurthy
- Department of Rheumatology, Evelina London Children's Hospital, London, UK
| | - E Lebas
- Dermatopathology, St John's Institute of Dermatology, London, UK
| | - E Calonje
- Dermatopathology, St John's Institute of Dermatology, London, UK
| | - S Baron
- Departments of, Dermatology, St John's Institute of Dermatology, London, UK
| | - W Abdelrahman
- Departments of, Dermatology, St John's Institute of Dermatology, London, UK
| |
Collapse
|
16
|
Jindal S, Serrano M, Baron S, Rikin S, Mehta V, Alexander M, Stuart M, Galeas J, Packer S, Grossberg R, Halmos B, Haramati L. P44.04 Evaluating Lung Cancer Screening in People Living With HIV. J Thorac Oncol 2021. [DOI: 10.1016/j.jtho.2021.01.843] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
17
|
El Allali Y, Hermetet C, Bacchetta J, Amouroux C, Rothenbuhler A, Porquet-Bordes V, Champigny MA, Baron S, Barat P, Bony-Trifunovic H, Bourdet K, Busiah K, Cartigny-Maciejewski M, Compain F, Coutant R, Amsellem-Jager J, De Kerdanet M, Magontier N, Mignot B, Richard O, Rossignol S, Soskin S, Berot A, Naud-Saudreau C, Salles JP, Linglart A, Edouard T, Lienhardt-Roussie A. Presenting features and molecular genetics of primary hyperparathyroidism in the paediatric population. Eur J Endocrinol 2021; 184:347-355. [PMID: 33361469 DOI: 10.1530/eje-20-1119] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 11/28/2020] [Indexed: 11/08/2022]
Abstract
AIM To describe the presenting features and molecular genetics of primary hyperparathyroidism (PHPT) in the paediatric population. METHODS Retrospective study of 63 children diagnosed with primary PHPT from 1998 to 2018. RESULTS Compared to older children, infants were often asymptomatic (54% vs 15%, P = 0.002) with a milder form of PHPT. When symptomatic, children and adolescents mostly presented with non-specific complaints such as asthenia, depression, weight loss, vomiting or abdominal pain. A genetic cause of PHPT was identified in about half of this cohort (52%). The infancy period was almost exclusively associated with mutation in genes involved in the calcium-sensing receptor (CaSR) signalling pathway (i.e. CaSR and AP2S1 genes, 'CaSR group'; 94% of infants with mutations) whereas childhood and adolescence were associated with mutation in genes involved in parathyroid cell proliferation (i.e. MEN1, CDC73, CDKN1B and RET genes, 'cell proliferation group'; 69% of children and adolescents with mutations). Although serum calcium levels did not differ between the two groups (P = 0.785), serum PTH levels and the urinary calcium/creatinine ratio were significantly higher in 'cell proliferation group' patients compared to those in the 'CaSR group' (P = 0.001 and 0.028, respectively). CONCLUSION Although far less common than in adults, PHPT can develop in children and is associated with significant morbidity. Consequently, this diagnosis should be considered in children with non-specific complaints and lead to monitoring of mineral homeostasis parameters. A genetic cause of PHPT can be identified in about half of these patients.
Collapse
Affiliation(s)
| | - Coralie Hermetet
- Epidemiology and Public Health Unit, Tours University Hospital, Tours, Centre, France
| | - Justine Bacchetta
- Service de Néphrologie, Rhumatologie et Dermatologie Pédiatriques, Centre de Référence des Maladies Rares du Calcium et du Phosphore, Hôpital Femme Mère Enfant, INSERM UMR 1033, Bron, France
| | - Cyril Amouroux
- Paediatric Unit, Montpellier University Hospital, Montpellier, Languedoc-Roussillon, France
| | - Anya Rothenbuhler
- Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre Paris Saclay, Endocrinology and Diabetology for Children, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, OSCAR Network, ERN BOND, Le Kremlin-Bicêtre, Toulouse, France
| | - Valérie Porquet-Bordes
- Endocrine, Bone Diseases, and Genetics Unit, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, OSCAR Network, ERN BOND, Children's Hospital, Toulouse University Hospital, INSERM UMR 1043/CNRS 5828, Paul Sabatier University, Toulouse, France
| | | | - Sabine Baron
- Paediatric Unit, Nantes University Hospital, Nantes, Pays de la Loire, France
| | - Pascal Barat
- Paediatric Unit, Bordeaux University Hospital, Bordeaux, Aquitaine, France
| | | | - Karine Bourdet
- Paediatric Unit, Brest University Hospital, Brest, Bretagne, France
| | - Kanetee Busiah
- Endocrinology and Diabetology for Children, Necker University Hospital, AP-HP, Paris, Île-de-France, France
| | | | | | - Régis Coutant
- Paediatric Endocrinology Department, Angers University Hospital, Angers, Pays de la Loire, France
| | - Jessica Amsellem-Jager
- Paediatric Endocrinology Department, Angers University Hospital, Angers, Pays de la Loire, France
| | - Marc De Kerdanet
- Paediatric Unit, Rennes University Hospital, Rennes, Bretagne, France
| | | | - Brigitte Mignot
- Paediatric Unit, Besançon University Hospital, Besançon, France
| | - Odile Richard
- Paediatric Unit, Saint-Etienne University Hospital, Saint-Etienne, Rhône-Alpes, France
| | - Sylvie Rossignol
- Paediatric Unit, Strasbourg University Hospital, Strasbourg, Alsace, France
| | - Sylvie Soskin
- Paediatric Unit, Strasbourg University Hospital, Strasbourg, Alsace, France
| | - Aurélie Berot
- Paediatric Unit, Reims University Hospital, Reims, Champagne-Ardenne, France
| | | | - Jean-Pierre Salles
- Endocrine, Bone Diseases, and Genetics Unit, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, OSCAR Network, ERN BOND, Children's Hospital, Toulouse University Hospital, INSERM UMR 1043/CNRS 5828, Paul Sabatier University, Toulouse, France
| | - Agnès Linglart
- Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Bicêtre Paris Saclay, Endocrinology and Diabetology for Children, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, OSCAR Network, ERN BOND, Le Kremlin-Bicêtre, Toulouse, France
| | - Thomas Edouard
- Endocrine, Bone Diseases, and Genetics Unit, Reference Centre for Rare Diseases of Calcium and Phosphate Metabolism, OSCAR Network, ERN BOND, Children's Hospital, Toulouse University Hospital, INSERM UMR 1043/CNRS 5828, Paul Sabatier University, Toulouse, France
| | | |
Collapse
|
18
|
Donzeau A, Bonnemaison E, Vautier V, Menut V, Houdon L, Bendelac N, Bismuth E, Bouhours-Nouet N, Quemener E, Baron S, Nicolino M, Faure N, Pochelu S, Barat P, Coutant R. Effects of advanced carbohydrate counting on glucose control and quality of life in children with type 1 diabetes. Pediatr Diabetes 2020; 21:1240-1248. [PMID: 32644264 DOI: 10.1111/pedi.13076] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/19/2020] [Revised: 06/22/2020] [Accepted: 06/30/2020] [Indexed: 02/01/2023] Open
Abstract
OBJECTIVE The effect of advanced carbohydrate counting (ACC) on metabolic and quality of life (QOL) outcomes is uncertain in children with type 1 diabetes. Our aim was to determine whether ACC would improve HbA1c and QOL scores as compared with standard nutrition in this population. METHODS We randomized 87 patients using pump and rapid-acting analogs in a 1 year randomized multicenter study (age 9.6 ± 3.5 years, diabetes duration 4.6 ± 2.7 years, HbA1c 7.8 ± 0.5% [62 ± 5 mmol/mol]). The ACC group received CC education and the control group received traditional dietary education. HbA1c was measured every 3 months. At 0 and 1 year, general, diabetes-specific, and diet-related QOL were respectively assessed by the KIDSCREEN and WHO-5 questionnaires, the diabetes-specific module of the DISABKIDS, and the diet restriction items of the DSQOLS. RESULTS Mean HbA1c was lower in the ACC than the control group at 3 months (P < .05) and tended to be lower at 6 months (P = .10), 9 months (P = .10), but not at 12 months. The mean of individual average HbA1c during the one-year study period (from M3 to M12) was 7.63 ± 0.43 in the ACC vs 7.85 ± 0.47% in the control group (60 ± 5 vs 62 ± 5 mmol/mol)(P < .05). ACC was associated with significantly higher scores at 1 year on the KIDSCREEN children's psychological scale and the KIDSCREEN parents' physical scale, the DISABKIDS children's treatment scale, and the children's and parents' dietary restriction scales of the DSQOLS (indicating better QOL or lower perceived diet restriction). CONCLUSIONS ACC may be associated with small improvements in metabolic control and QOL scores in children.
Collapse
Affiliation(s)
| | | | - Vanessa Vautier
- Pediatric Diabetology, University Hospital, Bordeaux, France
| | - Vanessa Menut
- Pediatric Diabetology, University Hospital, Nantes, France
| | - Laure Houdon
- Pediatric Diabetology, University Hospital, St Pierre de la Reunion, France
| | | | - Elise Bismuth
- Pediatric Diabetology, University Hospital, St Pierre de la Reunion, France
| | | | | | - Sabine Baron
- Pediatric Diabetology, University Hospital, Nantes, France
| | - Marc Nicolino
- Pediatric Diabetology, University Hospital, Lyon, France
| | - Nathalie Faure
- Pediatric Diabetology, University Hospital, Tours, France
| | - Sandra Pochelu
- Pediatric Diabetology, University Hospital, Bordeaux, France
| | - Pascal Barat
- Pediatric Diabetology, University Hospital, Bordeaux, France
| | - Regis Coutant
- Pediatric Diabetology, University Hospital, Angers, France
| |
Collapse
|
19
|
De Vleeschouwer F, Baron S, Cloy JM, Enrico M, Ettler V, Fagel N, Kempter H, Kylander M, Li C, Longman J, Martinez-Cortizas A, Marx S, Mattielli N, Mighall T, Nieminen TM, Piotrowska N, Pontevedra-Pombal X, Pratte S, Renson V, Shotyk W, Shuttleworth E, Sikorski J, Stromsoe N, Talbot J, von Scheffer C, Weiss D, Zaccone C, Le Roux G. Comment on: "A novel approach to peatlands as archives of total cumulative spatial pollution loads from atmospheric deposition of airborne elements complementary to EMEP data: Priority pollutants (Pb, Cd, Hg)" by Ewa Miszczak, Sebastian Stefaniak, Adam Michczyński, Eiliv Steinnes and Irena Twardowska. Sci Total Environ 2020; 737:138699. [PMID: 32376094 DOI: 10.1016/j.scitotenv.2020.138699] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Revised: 04/06/2020] [Accepted: 04/12/2020] [Indexed: 06/11/2023]
Abstract
A recent paper by Miszczak et al. (2020) examines metal contamination of mires in Poland and Norway. The authors conclude that lead (Pb) records in ombrotrophic peatlands cannot be used to reconstruct the chronological history of anthropogenic activities due to post-depositional mobility of the metal. We contest this general conclusion which stands in contrast with a significant body of literature demonstrating that Pb is largely immobile in the vast majority of ombrotrophic peatlands. Our aim is to reaffirm the crucial contribution that peat records have made to our knowledge of atmospheric Pb contamination. In addition, we reiterate the necessity of following established protocols to produce reliable records of anthropogenic Pb contamination in environmental archives.
Collapse
Affiliation(s)
- F De Vleeschouwer
- Instituto Franco-Argentino para el Estudio del Clima y sus Impactos (UMI IFAECI/CNRS-CONICET-UBA-IRD), Argentina.
| | - S Baron
- Laboratoire TRACES (CNRS, Université de Toulouse), France
| | - J M Cloy
- Scotland's Rural College, Edinburgh, UK
| | - M Enrico
- Harvard John A. Paulson School of Engineering and Applied Science, Harvard University, Cambridge, MA, USA
| | - V Ettler
- Charles University, Faculty of Science, Prague, Czech Republic
| | - N Fagel
- AGEs, Département de Géologie, Université de Liège, Belgium
| | - H Kempter
- Welzheimer Str. 14, D-71566 Althuette, Germany
| | - M Kylander
- Department of Geological Sciences and the Bolin Centre for Climate Research, Stockholm University, Sweden
| | - C Li
- Geoscience Environnement Toulouse (CNRS-UPS-IRD-CNAP-CNES), France
| | - J Longman
- School of Geography and the Environment, University of Oxford, UK
| | | | - S Marx
- GeoQuEST Research Centre, School of Earth, Atmospheric and Life Sciences, University of Wollongong, Australia
| | - N Mattielli
- Laboratoire G-Time, Université Libre de Bruxelles, Belgium
| | - T Mighall
- School of Geosciences, University of Aberdeen, UK
| | - T M Nieminen
- Natural Resources Institute Finland Luke, Helsinki, Finland
| | - N Piotrowska
- Silesian University of Technology, Institute of Physics-CSE, GADAM Center, Gliwice, Poland
| | | | - S Pratte
- Department of Geography, School of Earth Sciences, Zhejiang University, Hangzhou, China
| | - V Renson
- Research Reactor, University of Missouri, USA
| | - W Shotyk
- Department of Renewable Resources, University of Alberta, Edmonton, Canada
| | | | - J Sikorski
- Silesian University of Technology, Institute of Physics-CSE, GADAM Center, Gliwice, Poland
| | - N Stromsoe
- College of Engineering, IT and Environment, Charles Darwin University, Australia
| | - J Talbot
- Département de Géographie, Université de Montréal, Canada
| | - C von Scheffer
- Institute for Ecosystem Research, Kiel University, Germany
| | - D Weiss
- Imperial College London, UK; Princeton University, Princeton, USA
| | - C Zaccone
- Department of Biotechnology, University of Verona, Italy
| | - G Le Roux
- Laboratoire Ecologie Fonctionnelle et Environnement, Université de Toulouse, CNRS, Toulouse, France
| |
Collapse
|
20
|
Lecuyer AI, Baron S, Diguisto C, Laurent E, Turpin D, Potin J, Grammatico-Guillon L. [Cesarean sections in the Centre-Val de Loire region: Practices and indications-the Robson Classification]. Rev Epidemiol Sante Publique 2020; 68:253-259. [PMID: 32591237 DOI: 10.1016/j.respe.2020.05.007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/15/2019] [Revised: 05/27/2020] [Accepted: 05/30/2020] [Indexed: 11/17/2022] Open
Abstract
BACKGROUND To study the cesarean section (c-section) practices in the French Centre-Val de Loire region: incidence of planned c-section and rate variations between maternities, incidence of potentially avoidable cesarean sections. METHODS The data were extracted from the 2016 regional birth register, which permitted classification of each planned c-section according to the pre-existing risk of c-section (high or low) as defined by the Robson classification. To enhance the data, especially the indications for c-section, which are not included in the register, a survey was conducted from September 2016 to February 2017 in all of the 20 maternities in the region. RESULTS In 2016, nearly 26,000 women gave birth in the CVL region, of whom 19.2% by c-section (7.0% planned c-sections). The planned c-section rate was higher for breech presentation and scarred uterus, and decreased according to level of the maternity (I 41% - II 35% - III 32%). Concerning the c-section indications, 1,979 c-sections were studied during the period (18.6% of births), including 762 planned c-sections (7.1% of births). Among them, 246 (32%) were potentially avoidable, mainly isolated indications of scarred uterus with only one previous c-section or breech presentation, and 17 due to unfavorable radiologic pelvimetry in nulliparous women. CONCLUSION Specific actions were identified: targeted use of radiologic pelvimetry, targeted c-section on scarred uterus with only one previous cesarean section or breech presentation, as recommended by the national guidelines. The Robson classification should be widely used to evaluate and enhance practices, in particularly through painstakingly interpreted inter-maternity comparisons.
Collapse
Affiliation(s)
- A-I Lecuyer
- Public Health and Epidemiology Unit (EpiDcliC), Teaching hospital of Tours, 37044 Tours, France; Research Team "Education, Ethics and Health" (EA7505), University of Tours, 37044 Tours, France.
| | - S Baron
- Public Health and Epidemiology Unit (EpiDcliC), Teaching hospital of Tours, 37044 Tours, France; Research Team "Education, Ethics and Health" (EA7505), University of Tours, 37044 Tours, France
| | - C Diguisto
- Olympe De Gouges Obstetrics maternity unit, Teaching hospital of Tours, 37044 Tours, France; University of Tours, 37044 Tours, France
| | - E Laurent
- Public Health and Epidemiology Unit (EpiDcliC), Teaching hospital of Tours, 37044 Tours, France; Research Team "Education, Ethics and Health" (EA7505), University of Tours, 37044 Tours, France
| | - D Turpin
- Perinatality Health Network (RSP) of the Centre-Val de Loire region, 37044 Tours, France
| | - J Potin
- Olympe De Gouges Obstetrics maternity unit, Teaching hospital of Tours, 37044 Tours, France; Perinatality Health Network (RSP) of the Centre-Val de Loire region, 37044 Tours, France
| | - L Grammatico-Guillon
- Public Health and Epidemiology Unit (EpiDcliC), Teaching hospital of Tours, 37044 Tours, France; University of Tours, 37044 Tours, France
| |
Collapse
|
21
|
Baron S, Bridges J, McGrath N, Roberts HC, Ibrahim K. 92 Relocation in Care Homes (RICH) Study: The Experience of Different Stakeholders. Age Ageing 2020. [DOI: 10.1093/ageing/afz194.03] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Introduction
In the UK, care homes in unsuitable older buildings are closing. Involuntary relocation is associated with increased mortality and negative emotions among residents. Extensive planning can mitigate this. The aim was to understand the experience of a planned relocation between two care homes.
Methods
In the UK, care homes in unsuitable older buildings are closing. Involuntary relocation is associated with increased mortality and negative emotions among residents. Extensive planning can mitigate this. The aim was to understand the experience of a planned relocation between two care homes.
Results
Seven themes were identified and organised under three stages: pre-move (communication and involvement; preparation for the move; and attitudes towards the move), day-of-the-move (organisation of the move), and post-move (environmental change and impact; staff organisation and management; and settling in). Family and staff members reported that the pre-move information provided was inconsistent and staff did not feel involved in the planning and design process. Pre-move visits and staff and family support were beneficial for residents’ preparation for the move. All participants expressed sadness about the closure, and reported apprehension about moving. The moving day felt disorganised and stressful to staff who had to spread between the two homes. Post-move, the new care home was perceived by many participants as a ‘hotel’ rather than a home. Its larger size and confusing layout impacted negatively on residents and staff. New staff and changes in management structure were perceived by the different stakeholders to cause increased staff workload. Residents adjusted variably to the new home, with family support and staff continuity of care proving to be facilitators.
Conclusions
Despite extensive planning, relocation and adjustment was challenging. Recommendations for future relocations include: increasing involvement of staff in the planning and design of the home; ensuring consistent communication and organising staff rotas to maintain continuity of care.
Collapse
Affiliation(s)
- S Baron
- Faculty of Medicine, University of Southampton
| | - J Bridges
- Faculty of Environmental and Life Sciences, University of Southampton
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex; University of Southampton
| | - N McGrath
- Faculty of Medicine, University of Southampton
| | - H C Roberts
- Faculty of Medicine, University of Southampton
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex; University of Southampton
| | - K Ibrahim
- Faculty of Medicine, University of Southampton
- National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) Wessex; University of Southampton
| |
Collapse
|
22
|
Diallo O, Baron S, Jimeno M, Abat C, Dubourg G, Chaudet H, Raoult D, Rolain J. Hospital mortality and positive blood culture with Difficult-to threat (DTR), Marseille, France. J Infect Public Health 2020. [DOI: 10.1016/j.jiph.2020.01.035] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
23
|
Baron S, Cassir N, Hamel M, Hadjadj L, Saidani N, Dubourg G, Rolain J. Colistin-resistant Klebsiella pneumoniae ST307 clone: Epidemiological, risk factors and massive molecular analysis of bacterial genomes linked to an outbreak in Marseille, France. J Infect Public Health 2020. [DOI: 10.1016/j.jiph.2020.01.036] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
24
|
Casalta A, Baron S, Nivet Antoine V, Maruani G, Soulat G, Jean Louis P, Iserin L, Mousseaux E, Ladouceur M. Predictors of adverse cardiovascular event in patients with a systemic RV: A prospective cohort study. Archives of Cardiovascular Diseases Supplements 2020. [DOI: 10.1016/j.acvdsp.2019.09.336] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Stoupa A, Al Hage Chehade G, Chaabane R, Kariyawasam D, Szinnai G, Hanein S, Bole-Feysot C, Fourrage C, Nitschke P, Thalassinos C, Pinto G, Mnif M, Baron S, De Kerdanet M, Reynaud R, Barat P, Hachicha M, Belguith N, Polak M, Carré A. High Diagnostic Yield of Targeted Next-Generation Sequencing in a Cohort of Patients With Congenital Hypothyroidism Due to Dyshormonogenesis. Front Endocrinol (Lausanne) 2020; 11:545339. [PMID: 33692749 PMCID: PMC7937947 DOI: 10.3389/fendo.2020.545339] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/15/2020] [Accepted: 12/15/2020] [Indexed: 11/13/2022] Open
Abstract
OBJECTIVE To elucidate the molecular cause in a well-characterized cohort of patients with Congenital Hypothyroidism (CH) and Dyshormonogenesis (DH) by using targeted next-generation sequencing (TNGS). STUDY DESIGN We studied 19 well-characterized patients diagnosed with CH and DH by targeted NGS including genes involved in thyroid hormone production. The pathogenicity of novel mutations was assessed based on in silico prediction tool results, functional studies when possible, variant location in important protein domains, and a review of the recent literature. RESULTS TNGS with variant prioritization and detailed assessment identified likely disease-causing mutations in 10 patients (53%). Monogenic defects most often involved TG, followed by DUOXA2, DUOX2, and NIS and were usually homozygous or compound heterozygous. Our review shows the importance of the detailed phenotypic description of patients and accurate analysis of variants to provide a molecular diagnosis. CONCLUSIONS In a clinically well-characterized cohort, TNGS had a diagnostic yield of 53%, in accordance with previous studies using a similar strategy. TG mutations were the most common genetic defect. TNGS identified gene mutations causing DH, thereby providing a rapid and cost-effective genetic diagnosis in patients with CH due to DH.
Collapse
Affiliation(s)
- Athanasia Stoupa
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Ghada Al Hage Chehade
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Rim Chaabane
- Laboratory of Human Molecular Genetics, Medicine School, University of Sfax, Sfax, Tunisia
| | - Dulanjalee Kariyawasam
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Gabor Szinnai
- Pediatric Immunology, Department of Biomedicine, University of Basel, Basel, Switzerland
- Pediatric Endocrinology, University Children’s Hospital Basel, University of Basel, Basel, Switzerland
| | - Sylvain Hanein
- INSERM U1163, IMAGINE Institute, Translational Genetics, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
| | - Christine Bole-Feysot
- Genomics Platform, INSERM UMR 1163, Paris Descartes Sorbonne Paris Cite University, Imagine Institute, Paris, France
| | - Cécile Fourrage
- Bioinformatics Platform, Paris Descartes University, IMAGINE Institute, Paris, France
| | - Patrick Nitschke
- Bioinformatics Platform, Paris Descartes University, IMAGINE Institute, Paris, France
| | - Caroline Thalassinos
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Graziella Pinto
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
| | - Mouna Mnif
- Endocrinology Department, CHU Hedi Chaker, Sfax, Tunisia
| | - Sabine Baron
- Pediatrics Department, CHU Nantes, Nantes, France
| | | | | | - Pascal Barat
- CHU de Bordeaux, Pediatric Endocrinology, Bordeaux, France
| | | | - Neila Belguith
- Laboratory of Human Molecular Genetics, Medicine School, University of Sfax, Sfax, Tunisia
- Medical Genetics Department, CHU Hedi Chaker, Sfax, Tunisia
| | - Michel Polak
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
- Pediatric Endocrinology, Gynecology and Diabetology Unit, Hôpital Universitaire Necker-Enfants Malades, AP-HP, Paris, France
- Centre de Référence des Maladies Endocriniennes Rares de la Croissance et du Développement, Necker-Enfants Malades University Hospital, Paris, France
- Centre Régional de Dépistage Néonatal (CRDN) Ile de France, Paris, France
- *Correspondence: Michel Polak, ; Aurore Carré,
| | - Aurore Carré
- INSERM U1016, Cochin Institute, Faculté de Médecine, Université Paris Descartes, Sorbonne Paris Cité, Paris, France
- IMAGINE Institute affiliate, Paris, France
- *Correspondence: Michel Polak, ; Aurore Carré,
| |
Collapse
|
26
|
Sobhani I, Itti E, Luciani A, Baumgaertner I, Layese R, André T, Ducreux M, Gornet JM, Goujon G, Aparicio T, Taieb J, Bachet JB, Hemery F, Retbi A, Mons M, Flicoteaux R, Rhein B, Baron S, Cherrak I, Rufat P, Le Corvoisier P, de'Angelis N, Natella PA, Maoulida H, Tournigand C, Durand Zaleski I, Bastuji-Garin S. Colorectal cancer (CRC) monitoring by 6-monthly 18FDG-PET/CT: an open-label multicentre randomised trial. Ann Oncol 2019; 29:931-937. [PMID: 29365058 PMCID: PMC5913635 DOI: 10.1093/annonc/mdy031] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Background [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography (18FDG-PET/CT) has high sensitivity for detecting recurrences of colorectal cancer (CRC). Our objective was to determine whether adding routine 6-monthly 18FDG-PET/CT to our usual monitoring strategy improved patient outcomes and to assess the effect on costs. Patients and methods In this open-label multicentre trial, patients in remission of CRC (stage II perforated, stage III, or stage IV) after curative surgery were randomly assigned (1 : 1) to usual monitoring alone (3-monthly physical and tumour marker assays, 6-monthly liver ultrasound and chest radiograph, and 6-monthly whole-body computed tomography) or with 6-monthly 18FDG-PET/CT, for 3 years. A multidisciplinary committee reviewed each patient’s data every 3 months and classified the recurrence status as yes/no/doubtful. Recurrences were treated with curative surgery alone if feasible and with chemotherapy otherwise. The primary end point was treatment failure defined as unresectable recurrence or death. Relative risks were estimated, and survival was analysed using the Kaplan–Meier method, log-rank test, and Cox models. Direct costs were compared. Results Of the 239 enrolled patients, 120 were in the intervention arm and 119 in the control arm. The failure rate was 29.2% (31 unresectable recurrences and 4 deaths) in the intervention group and 23.7% (27 unresectable recurrences and 1 death) in the control group (relative risk = 1.23; 95% confidence interval, 0.80–1.88; P = 0.34). The multivariate analysis also showed no significant difference (hazards ratio, 1.33; 95% confidence interval, 0.8–2.19; P = 0.27). Median time to diagnosis of unresectable recurrence (months) was significantly shorter in the intervention group [7 (3–20) versus 14.3 (7.3–27), P = 0.016]. Mean cost/patient was higher in the intervention group (18 192 ± 27 679 € versus 11 131 ± 13 €, P < 0.033). Conclusion 18FDG-PET/CT, when added every 6 months, increased costs without decreasing treatment failure rates in patients in remission of CRC. The control group had very close follow-up, and any additional improvement (if present) would be small and hard to detect. ClinicalTrials.gov identifier NCT00624260
Collapse
Affiliation(s)
- I Sobhani
- EA7375 (EC2M3 Research Team), Université Paris-Est Créteil (UPEC)-Val de Marne, Créteil, France; Department of Gastroenterology, APHP-Hôpital Henri Mondor, Créteil, France.
| | - E Itti
- Department of Nuclear Medicine, APHP-Hôpital Henri Mondor, Créteil, France
| | - A Luciani
- Department of Medical Imaging, APHP-Hôpital Henri Mondor, Créteil, France
| | - I Baumgaertner
- EA7375 (EC2M3 Research Team), Université Paris-Est Créteil (UPEC)-Val de Marne, Créteil, France
| | - R Layese
- Public Health, Unité de Recherche Clinique (URC Mondor), APHP-Hôpital Henri Mondor, Créteil, France; CEpiA Clinical Epidemiology and Ageing Un, EA7376, Université Paris-Est (UPEC), A-TVB DHU, IMRB, Créteil, France
| | - T André
- Sorbonnes University and Department of Medical Oncology, APHP-Hôpital St Antoine, Paris, France
| | - M Ducreux
- Department of Gastrointestinal Oncology, Institut Gustave Roussy, Villejuif, France
| | - J-M Gornet
- Department of Gastroenterology, APHP-Hôpital St Louis, Paris, France
| | - G Goujon
- Department of Gastroenterology, APHP-Hôpital Bichat, Paris, France
| | - T Aparicio
- Department of Gastroenterology, APHP-Hôpital Avicenne, Paris, France
| | - J Taieb
- Department of Gastrointestinal Oncology, APHP-Hôpital Européen Georges Pompidou, Paris, France
| | - J-B Bachet
- Department of Gastroenterology and Medical Informatics, APHP-Hôpital Pitié-Salpêtrière, Paris, France
| | - F Hemery
- Department of Medical Informatics, APHP-Hôpital Henri Mondor, Créteil, France
| | - A Retbi
- Sorbonnes University and Department of Medical Oncology, APHP-Hôpital St Antoine, Paris, France
| | - M Mons
- Department of Gastrointestinal Oncology, Institut Gustave Roussy, Villejuif, France
| | - R Flicoteaux
- Department of Gastroenterology, APHP-Hôpital St Louis, Paris, France
| | - B Rhein
- Department of Medical Informatics, Centre Hospitalier d'Intercommunal de Créteil, Créteil, France
| | - S Baron
- Department of Gastroenterology, APHP-Hôpital Avicenne, Paris, France
| | - I Cherrak
- Department of Gastrointestinal Oncology, APHP-Hôpital Européen Georges Pompidou, Paris, France
| | - P Rufat
- Department of Gastroenterology and Medical Informatics, APHP-Hôpital Pitié-Salpêtrière, Paris, France
| | - P Le Corvoisier
- Clinical Investigations Centre, APHP-Hôpital Henri Mondor, Créteil, France
| | - N de'Angelis
- EA7375 (EC2M3 Research Team), Université Paris-Est Créteil (UPEC)-Val de Marne, Créteil, France
| | - P-A Natella
- Public Health, Unité de Recherche Clinique (URC Mondor), APHP-Hôpital Henri Mondor, Créteil, France
| | - H Maoulida
- Healthcare Economics Research Unit, APHP, Paris, France, France
| | - C Tournigand
- EA7375 (EC2M3 Research Team), Université Paris-Est Créteil (UPEC)-Val de Marne, Créteil, France
| | | | - S Bastuji-Garin
- Public Health, Unité de Recherche Clinique (URC Mondor), APHP-Hôpital Henri Mondor, Créteil, France; CEpiA Clinical Epidemiology and Ageing Un, EA7376, Université Paris-Est (UPEC), A-TVB DHU, IMRB, Créteil, France
| |
Collapse
|
27
|
Laurent E, Lecuyer AI, Baron S, Diguisto C, Turpin D, Potin J, Grammatico-Guillon L. Indications and practices of Cesarean Sections in a French region – The Robson classification. Eur J Public Health 2019. [DOI: 10.1093/eurpub/ckz186.130] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Background
Cesarian-section (CS) deliveries, although sometimes vital, are associated with increasing immediate- and long-term maternal and/or neonatal risks. The objective was to describe the indications of scheduled CS, measure the potentially avoidable CS and study the rate variations between maternities in one French region, Centre Val-de-Loire (CVL).
Methods
A cross-sectional study was conducted from September 2016 to February 2017. Information about all CS performed in the maternities of the region was collected: medical history, indication, schedule. Data collection was completed with the 2016 regional birth data repository (25,864 deliveries, including 19.2% of CS, among which 7.0% were scheduled). CS were classified according to the pre-existing risk high or low of CS as defined by the Robson classification.
Results
During the study period, 1,979 CS (18.6% of deliveries) were performed, of which 762 were scheduled (7.1% of deliveries). The main indications for planning a CS were: scarred uterus (60%, of which 56% with only one previous CS) or breech presentation (25%), considered at high risk of CS according to the Robson classification. For these two contexts, the regional birth repository showed decreasing scheduled CS rates from high to low level of maternities’ expertise. Remarkly, 22 nulliparous women with a single cephalic pregnancy in spontaneous labor before term (Robson’s low risk of CS) had a CS performed for unfavorable pelvimetry (0.2% of deliveries).
Conclusions
This study allowed identifying specific potential interventions: targeted CS on scarred uterus with only one previous CS or breech presentation, as recommended by national guidelines, and targeted use of radiologic pelvimetry. The Robson classification must be widely used to assess practices through cautious maternity comparisons to improve quality of care.
Key messages
Although potentially avoidable c-sections are rare, interventions were identified: targeted CS on uterus with one previous CS or breech presentation, targeted use of radiologic pelvimetry. The Robson classification must be widely used to assess practices, in order to improve healthcare quality.
Collapse
Affiliation(s)
- E Laurent
- Public Health Unit, Teaching Hospital of Tours, Tours, France
- Research Team “Education, Ethique, Santé” (EA7505), University of Tours, Tours, France
| | - A I Lecuyer
- Public Health Unit, Teaching Hospital of Tours, Tours, France
- Research Team “Education, Ethique, Santé” (EA7505), University of Tours, Tours, France
| | - S Baron
- Public Health Unit, Teaching Hospital of Tours, Tours, France
- Research Team “Education, Ethique, Santé” (EA7505), University of Tours, Tours, France
| | - C Diguisto
- Obstetric Unit – Olympe de Gouges Maternity, Teaching Hospital of Tours, Tours, France
- University of Tours, Tours, France
| | - D Turpin
- Perinatal Healthcare Network - Centre Val-de-Loire, Perinatal Healthcare Network of the Centre Val-de-Loire Region, Tours, France
| | - J Potin
- Obstetric Unit – Olympe de Gouges Maternity, Teaching Hospital of Tours, Tours, France
- Perinatal Healthcare Network - Centre Val-de-Loire, Perinatal Healthcare Network of the Centre Val-de-Loire Region, Tours, France
| | - L Grammatico-Guillon
- Public Health Unit, Teaching Hospital of Tours, Tours, France
- University of Tours, Tours, France
| |
Collapse
|
28
|
Cornu E, Belmihoub I, Burnichon N, Grataloup C, Zinzindohoué F, Baron S, Billaud E, Azizi M, Gimenez-Roqueplo AP, Amar L. Phéochromocytome et paragangliome. Rev Med Interne 2019; 40:733-741. [DOI: 10.1016/j.revmed.2019.07.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2019] [Revised: 06/27/2019] [Accepted: 07/17/2019] [Indexed: 12/20/2022]
|
29
|
Lauck S, Baron S, Sathananthan J, Humphries K, Webb J, Wood D, David C. CHANGES IN PATIENT-REPORTED OUTCOMES AFTER TRANSCATHETER AORTIC VALVE IMPLANTATION: INSIGHTS FROM THE 3M TAVR STUDY. Can J Cardiol 2019. [DOI: 10.1016/j.cjca.2019.07.448] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
30
|
Bizaoui V, Michot C, Baujat G, Amouroux C, Baron S, Capri Y, Cohen-Solal M, Collet C, Dieux A, Geneviève D, Isidor B, Monnot S, Rossi M, Rothenbuhler A, Schaefer E, Cormier-Daire V. Pycnodysostosis: Natural history and management guidelines from 27 French cases and a literature review. Clin Genet 2019; 96:309-316. [PMID: 31237352 DOI: 10.1111/cge.13591] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2019] [Revised: 05/29/2019] [Accepted: 06/03/2019] [Indexed: 01/25/2023]
Abstract
Pycnodysostosis is a lysosomal autosomal recessive skeletal dysplasia characterized by osteosclerosis, short stature, acro-osteolysis, facial features and an increased risk of fractures. The clinical heterogeneity of the disease and its rarity make it difficult to provide patients an accurate prognosis, as well as appropriate care and follow-up. French physicians from the OSCAR network have been asked to fill out questionnaires collecting molecular and clinical data for 27 patients issued from 17 unrelated families. All patients showed short stature (mean = -3.5 SD) which was more severe in females (P = .006). The mean fracture rate was moderate (0.21 per year), with four fractures in total average. About 75% underwent at least one surgery, with an average number of 2.1 interventions per patient. About 50% required non-invasive assisted ventilation due to sleep apnea (67%). About 29% showed psychomotor difficulties and 33% needed a school assistant or adapted schooling. No patient had any psychological evaluation or follow-up. Molecular data were available for 14 families. Growth hormone administration was efficient on linear growth in 40% of cases. We propose several axis of management, such as systematic cerebral MRI for Chiari malformation screening at diagnosis and regular psychological follow-up.
Collapse
Affiliation(s)
- Varoona Bizaoui
- Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France
| | - Caroline Michot
- Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France
| | - Geneviève Baujat
- Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France
| | - Cyril Amouroux
- Department of Paediatric Endocrinology, Arnaud de Villeneuve Hospital, Montpellier, France
| | - Sabine Baron
- Service de Génétique Médicale, CHU de Nantes, Nantes, France
| | - Yline Capri
- Genetics Department, AP-HP, Robert-Debré University Hospital, Paris, France
| | - Martine Cohen-Solal
- Department of Rheumatology, Lariboisière Hospital, INSERM U1132 and University Paris-Diderot, Paris, France
| | - Corinne Collet
- Department of Biochemistry, APHP, Saint-Louis Lariboisière Hospitals, Paris, France
| | - Anne Dieux
- Centre de Référence CLAD NdF, Service de Génétique Clinique, Hôpital Jeanne de Flandre, CHU Lille, France
| | - David Geneviève
- Service de Génétique Clinique et du Département de Génétique Médicale, Maladies Rares et Médecine Personnalisée, Centre de Compétence Maladies Osseuses Constitutionnelles, Inserm U1183, Université Montpellier, Montpellier, France
| | - Bertrand Isidor
- Service de Génétique Médicale, CHU de Nantes, Nantes, France
| | - Sophie Monnot
- Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France
| | - Massimiliano Rossi
- Hospices Civils de Lyon, Service de Génétique, Centre de Référence Anomalies du Développement, Bron, France.,Centre de Recherche en Neurosciences de Lyon, INSERM U1028, CNRS UMR5292, UCB Lyon 1, Lyon, France
| | - Anya Rothenbuhler
- Department of Paediatric Endocrinology, Bicêtre Hospital, Paris, France
| | - Elise Schaefer
- Service de Génétique Médicale, Institut de Génétique Médicale d'Alsace, Hôpitaux Universitaires de Strasbourg, Strasbourg, France
| | - Valérie Cormier-Daire
- Department of Medical Genetics, Reference Center for Skeletal Dysplasia and OSCAR Network, Paris Descartes-Sorbonne Paris Cité University, INSERM UMR 1163, Instititut Imagine, Hôpital Necker Enfants Malades, Paris, France
| |
Collapse
|
31
|
Abstract
Alongside imaging techniques, pulmonary function testing helps in the diagnosis of underlying disorders such as asthma and chronic obstructive pulmonary disease (COPD) or fibrosing lung disease. However, disease severity grading is also important, as well as disease follow-up under therapy. The value of spirometry as a first-line diagnostic test, whole-body plethysmography in advanced diagnostics, the measurement of transfer factor, as well as blood gas analysis are outlined. The importance of spiroergometry, echocardiography, and right-heart catheterization, particularly in the functional assessment of pulmonary vascular disorders, is described. Tests in respiratory sleep medicine, such as polysomnography, as well as tests for diagnosing chronic respiratory failure, are part of the respiratory physician's diagnostic armamentarium.
Collapse
Affiliation(s)
- M Held
- Innere Medizin, Klinikum Würzburg Mitte - Standort Missioklinik, Salvatorstr. 7, 97064, Würzburg, Deutschland.
| | - S Baron
- Innere Medizin, Klinikum Würzburg Mitte - Standort Missioklinik, Salvatorstr. 7, 97064, Würzburg, Deutschland
| | - B Jany
- Innere Medizin, Klinikum Würzburg Mitte - Standort Missioklinik, Salvatorstr. 7, 97064, Würzburg, Deutschland
| |
Collapse
|
32
|
Baron S, Blanchard M, Parodi M, Rouillon I, Loundon N. Sequential bilateral cochlear implants in children and adolescents: Outcomes and prognostic factors. Eur Ann Otorhinolaryngol Head Neck Dis 2019; 136:69-73. [DOI: 10.1016/j.anorl.2018.09.004] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
33
|
Laurent E, Lecuyer AI, Baron S, Turpin D, Potin J, Grammatico-Guillon L. Césariennes programmées en Centre-Val de Loire : pratiques et Indications – Comparaison des taux selon la classification de Robson. Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.01.029] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
34
|
Laurent O, Godillon L, Biotteau M, Baron S, Grammatico-Guillon L, Laurent E. Soins sans consentement en psychiatrie adulte en Centre-Val de Loire : PMSI 2012–2017. Rev Epidemiol Sante Publique 2019. [DOI: 10.1016/j.respe.2019.01.043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
35
|
Irvine A, Jones A, Beattie P, Baron S, Browne F, Ashoor F, O'Neill L, Rosala-Hallas A, Sach T, Spowart C, Taams L, Walker C, Wan M, Webb N, Williamson P, Flohr C. The TREatment of severe Atopic eczema Trial (TREAT). Br J Dermatol 2018. [DOI: 10.1111/bjd.17052] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
36
|
Irvine AD, Jones AP, Beattie P, Baron S, Browne F, Ashoor F, O'Neill L, Rosala-Hallas A, Sach T, Spowart C, Taams L, Walker C, Wan M, Webb N, Williamson P, Flohr C. A randomized controlled trial protocol assessing the effectiveness, safety and cost-effectiveness of methotrexate vs. ciclosporin in the treatment of severe atopic eczema in children: the TREatment of severe Atopic eczema Trial (TREAT). Br J Dermatol 2018; 179:1297-1306. [PMID: 29727479 DOI: 10.1111/bjd.16717] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/23/2018] [Indexed: 11/27/2022]
Abstract
BACKGROUND Oral systemic immunomodulatory medication is regularly used off-licence in children with severe atopic eczema. However, there is no firm evidence regarding the effectiveness, safety, cost-effectiveness and impact on quality of life from an adequately powered randomized controlled trial (RCT) using systemic medication in children. OBJECTIVES To assess whether there is a difference in the speed of onset, effectiveness, side-effect profile and reduction in flares post-treatment between ciclosporin (CyA) and methotrexate (MTX), and also the cost-effectiveness of the drugs. Treatment impact on quality of life will also be examined in addition to whether FLG genotype influences treatment response. In addition, the trial studies the immune-metabolic effects of CyA and MTX. METHODS Multicentre, parallel group, assessor-blind, pragmatic RCT of 36 weeks' duration with a 24-week follow-up period. In total, 102 children aged 2-16 years with moderate-to-severe atopic eczema, unresponsive to topical treatment will be randomized (1 : 1) to receive MTX (0·4 mg kg-1 per week) or CyA (4 mg kg-1 per day). RESULTS The trial has two primary outcomes: change from baseline to 12 weeks in Objective Severity Scoring of Atopic Dermatitis (o-SCORAD) and time to first significant flare following treatment cessation. CONCLUSIONS This trial addresses important therapeutic questions, highlighted in systematic reviews and treatment guidelines for atopic eczema. The trial design is pragmatic to reflect current clinical practice.
Collapse
Affiliation(s)
- A D Irvine
- Clinical Medicine, Trinity College Dublin, Dublin, Ireland.,Paediatric Dermatology, Our Lady's Children Hospital Crumlin, Dublin, Ireland.,National Children's Research Centre, Crumlin, Dublin, Ireland
| | - A P Jones
- Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, U.K
| | - P Beattie
- Royal Hospital for Children NHS Trust, Glasgow, U.K
| | - S Baron
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K
| | - F Browne
- Paediatric Dermatology, Our Lady's Children Hospital Crumlin, Dublin, Ireland
| | - F Ashoor
- Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, U.K
| | - L O'Neill
- Biochemistry, Trinity College Dublin, Dublin, Ireland
| | - A Rosala-Hallas
- Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, U.K
| | - T Sach
- Health Economics Group, Norwich Medical School, University of East Anglia, Norwich, U.K
| | - C Spowart
- Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, U.K
| | - L Taams
- Centre for Molecular and Cellular Biology of Inflammation, King's College London, London, U.K
| | - C Walker
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K
| | - M Wan
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K
| | - N Webb
- Renal Research Laboratories, Manchester Royal Infirmary, Manchester, U.K
| | - P Williamson
- Clinical Trials Research Centre, Department of Biostatistics, University of Liverpool, Liverpool, U.K
| | - C Flohr
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K
| | -
- Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust and King's College London, London, U.K
| |
Collapse
|
37
|
Dumeige L, Chatelais L, Bouvattier C, De Kerdanet M, Hyon C, Esteva B, Samara-Boustani D, Zenaty D, Nicolino M, Baron S, Metz-Blond C, Naud-Saudreau C, Dupuis C, Léger J, Siffroi JP, Donadille B, Christin-Maitre S, Carel JC, Coutant R, Martinerie L. Should 45,X/46,XY boys with no or mild anomaly of external genitalia be investigated and followed up? Eur J Endocrinol 2018; 179:181-190. [PMID: 29973376 DOI: 10.1530/eje-18-0309] [Citation(s) in RCA: 15] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/12/2018] [Accepted: 07/03/2018] [Indexed: 12/13/2022]
Abstract
OBJECTIVE Few studies of patients with a 45,X/46,XY mosaicism have considered those with normal male phenotype. The purpose of this study was to evaluate the clinical outcome of 45,X/46,XY boys born with normal or minor abnormalities of external genitalia, notably in terms of growth and pubertal development. METHODS Retrospective longitudinal study of 40 patients followed between 1982 and 2017 in France. RESULTS Twenty patients had a prenatal diagnosis, whereas 20 patients had a postnatal diagnosis, mainly for short stature. Most patients had stunted growth, with abnormal growth spurt during puberty and a mean adult height of 158 ± 7.6 cm, i.e. -2.3 DS with correction for target height. Seventy percent of patients presented Turner-like syndrome features including cardiac (6/23 patients investigated) and renal malformations (3/19 patients investigated). Twenty-two patients had minor abnormalities of external genitalia. One patient developed a testicular embryonic carcinoma, suggesting evidence of partial gonadal dysgenesis. Moreover, puberty occurred spontaneously in 93% of patients but 71% (n = 5) of those evaluated at the end of puberty presented signs of declined Sertoli cell function (low inhibin B levels and increased FSH levels). CONCLUSION This study emphasizes the need to identify and follow-up 45,X/46,XY patients born with normal male phenotype until adulthood, as they present similar prognosis than those born with severe genital anomalies. Currently, most patients are diagnosed in adulthood with azoospermia, consistent with our observations of decreased testicular function at the end of puberty. Early management of these patients may lead to fertility preservation strategies.
Collapse
Affiliation(s)
- Laurence Dumeige
- Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France
- INSERM UMR-S1185, Le Kremlin Bicêtre, France
| | | | - Claire Bouvattier
- Pediatric Endocrinology Department, CHU Bicêtre, Centre de Référence des Anomalies du Développement Génital, Assistance-Publique Hôpitaux de Paris, Le Kremlin-Bicêtre, France
| | | | - Capucine Hyon
- Genetic Department, CHU Armand Trousseau, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Blandine Esteva
- Pediatric Endocrinology Department, CHU Armand Trousseau, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Dinane Samara-Boustani
- Pediatric Endocrinology Department, CHU Necker-Enfants Malades, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Delphine Zenaty
- Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France
| | - Marc Nicolino
- Pediatric Endocrinology Department, CHU Lyon, Centre de Référence des Anomalies du Développement Génital, Lyon, France
| | | | | | | | | | - Juliane Léger
- Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France
| | - Jean-Pierre Siffroi
- Genetic Department, CHU Armand Trousseau, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Bruno Donadille
- Endocrinology Department, CHU St-Antoine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Sophie Christin-Maitre
- Endocrinology Department, CHU St-Antoine, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris, Paris, France
| | - Jean-Claude Carel
- Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France
| | | | - Laetitia Martinerie
- Pediatric Endocrinology Department, CHU Robert Debré, Centre de Référence des Maladies Endocriniennes Rares de la Croissance, Assistance-Publique Hôpitaux de Paris and Université Paris Diderot, Sorbonne Paris Cité, Paris, France
- INSERM UMR-S1185, Le Kremlin Bicêtre, France
| |
Collapse
|
38
|
Mangin O, Bertocchio J, Baron S, Maruani G, Houillier P, Benveniste O, Allenbach Y. Estimation du débit de filtration glomérulaire : des insuffisances rénales méconnues au cours de la myosite à inclusions. Rev Med Interne 2018. [DOI: 10.1016/j.revmed.2018.03.312] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
39
|
Laurent E, Gras G, Druon J, Rosset P, Baron S, Le-Louarn A, Rusch E, Bernard L, Grammatico-Guillon L. Key features of bone and joint infections following the implementation of reference centers in France. Med Mal Infect 2018. [PMID: 29526340 DOI: 10.1016/j.medmal.2018.02.004] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/25/2023]
Abstract
OBJECTIVES French reference centers for bone and joint infections (BJI) were implemented from 2009 onwards to improve the management of complex BJIs. This study compared BJI burden before and after the implementation of these reference centers. PATIENTS AND METHODS BJI hospital stays were selected from the 2008 and 2013 national hospital discharge database using a validated algorithm, adding the new complex BJI code created in 2011. Epidemiology and economic burden were assessed. RESULTS BJI prevalence increased in 2013 (70 vs. 54/100,000 in 2008). Characteristics of BJI remained similar between 2008 and 2013: septic arthritis (50%), increasing prevalence with age and sex, case fatality 5%, mean length of stay 17.5 days, rehospitalization 20%. However, device-associated BJIs increased (34 vs. 26%) as well as costs (€421 million vs. €259 in 2008). Similar device-associated BJI characteristics between 2008 and 2013 were: septic arthritis (70%), case fatality (3%), but with more hospitalizations in reference centers (34 vs. 30%) and a higher cost per stay. Among the 7% of coded complex BJIs, the mean length of stay was 22.2 days and mean cost was €11,960. CONCLUSIONS BJI prevalence highly increased in France. Complex BJI prevalence assessment is complicated by the absence of clinical consensus and probable undercoding. A validation of clinical case definition of complex BJI is required.
Collapse
Affiliation(s)
- E Laurent
- Unité régionale d'épidémiologie hospitalière (UREH), Centre-Val de Loire, Centre Hospitalier régional universitaire (CHRU) de Tours, 37000 Tours, France; Équipe de Recherche EE1 EES, université de Tours, 37000 Tours, France.
| | - G Gras
- Service de maladies infectieuses, CHRU de Tours, 37000 Tours, France
| | - J Druon
- Service de chirurgie orthopédique, CHRU de Tours, 37000 Tours, France
| | - P Rosset
- Service de chirurgie orthopédique, CHRU de Tours, 37000 Tours, France; Faculté de médecine, université de Tours, 37000 Tours, France
| | - S Baron
- Unité régionale d'épidémiologie hospitalière (UREH), Centre-Val de Loire, Centre Hospitalier régional universitaire (CHRU) de Tours, 37000 Tours, France; Équipe de Recherche EE1 EES, université de Tours, 37000 Tours, France
| | - A Le-Louarn
- Unité régionale d'épidémiologie hospitalière (UREH), Centre-Val de Loire, Centre Hospitalier régional universitaire (CHRU) de Tours, 37000 Tours, France
| | - E Rusch
- Unité régionale d'épidémiologie hospitalière (UREH), Centre-Val de Loire, Centre Hospitalier régional universitaire (CHRU) de Tours, 37000 Tours, France; Équipe de Recherche EE1 EES, université de Tours, 37000 Tours, France
| | - L Bernard
- Service de maladies infectieuses, CHRU de Tours, 37000 Tours, France; Faculté de médecine, université de Tours, 37000 Tours, France
| | - L Grammatico-Guillon
- Unité régionale d'épidémiologie hospitalière (UREH), Centre-Val de Loire, Centre Hospitalier régional universitaire (CHRU) de Tours, 37000 Tours, France; Faculté de médecine, université de Tours, 37000 Tours, France
| |
Collapse
|
40
|
Baron S, Diallo A, Duclos C. Comment s’assurer que le codage clinique est bien réalisé ? Une proposition méthodologique. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.01.076] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
41
|
Nadjib AM, Attoh-Touré H, Abdel-Mahamoud A, Baron S, Brunet-Houdard S, Rusch E, Grammatico-Guillon L. Connaissances, attitudes et pratiques des parents face à la vaccination contre la poliomyélite à Abéché-Tchad. Pan Afr Med J 2018; 31:219. [PMID: 31452828 PMCID: PMC6693789 DOI: 10.11604/pamj.2018.31.219.12966] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/05/2017] [Accepted: 05/29/2018] [Indexed: 11/12/2022] Open
Abstract
Introduction au Tchad, la transmission de la poliomyélite a été interrompue en 2000, mais les importations à partir du Nigéria et la faiblesse des couvertures vaccinales constituent un risque majeur de relance de la maladie. L'objectif de ce travail était d'analyser les connaissances, attitudes et pratiques des parents vis-à-vis de la vaccination contre la poliomyélite des enfants âgés de 0 à 5 ans au Tchad. Méthodes cette étude transversale a été réalisée dans les six arrondissements d'Abéché. Seuls les ménages qui avaient des enfants de moins de 5 ans ont été inclus. Les données ont été recueillies par des entretiens avec les parents et tuteurs d'enfants éligibles à l'aide d'un questionnaire testé et validé. Résultats nous avons interrogé 210 ménages. Aucune famille ne possédait de carnet de vaccination de leurs enfants. Cependant, 97% ont déclaré avoir des enfants ayant participé aux campagnes de vaccination de masse. Près de 97% connaissaient la poliomyélite et 98% avaient entendu parler des campagnes de vaccination. Les canaux d'information les plus cités étaient la radio (98%) et les agents vaccinateurs (72%). Seul 3% des parents interrogés ont déclaré avoir refusé la vaccination. Il existait une association entre l'influence négative de l'entourage et la non vaccination des enfants (p = 0,005). Conclusion les connaissances sur la maladie et le vaccin sont bonnes au Tchad malgré l'existence de rumeurs concernant notamment les effets des vaccins. L'absence de carnet de vaccination a limité l'analyse des résultats de l'enquête, uniquement déclarative avec un taux de vaccination très élevé déclaré. Dans le cadre de l'éradication, le carnet est indispensable pour accompagner la politique de prévention.
Collapse
Affiliation(s)
- Abderahim Mahamat Nadjib
- Institut National Supérieur des Sciences et Techniques d'Abéché, Tchad
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
| | - Harvey Attoh-Touré
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
- Département de Santé Publique, Université F Houphouët-Boigny d'Abidjan, Côte d'Ivoire
| | - Adam Abdel-Mahamoud
- Institut National Supérieur des Sciences et Techniques d'Abéché, Tchad
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
| | - Sabine Baron
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
- SIMEES, Unité Régionale d'Epidémiologie Hospitalière, CHRU de Tours
| | - Solène Brunet-Houdard
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
- SIMEES, Unité d'Évaluation Médico-Economique, CHRU de Tours
- Faculté de Médecine, Université François Rabelais, Tours, France
| | - Emmanuel Rusch
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
- SIMEES, Unité Régionale d'Epidémiologie Hospitalière, CHRU de Tours
- SIMEES, Unité d'Évaluation Médico-Economique, CHRU de Tours
- Faculté de Médecine, Université François Rabelais, Tours, France
| | - Leslie Grammatico-Guillon
- Laboratoire de Santé Publique, EE1 EES, Université François Rabelais, Tours, France
- SIMEES, Unité Régionale d'Epidémiologie Hospitalière, CHRU de Tours
- Faculté de Médecine, Université François Rabelais, Tours, France
| |
Collapse
|
42
|
Benainous R, Elourimi G, Abad S, Mazoyer E, Warzocha U, Baron S, Le Jeune S, Lopez-Sublet M, Giroux-Leprieur B, Larroche C, Mourad J, Dhôte R. Évaluation de la morbi-mortalité à deux ans des patients traités pour une fibrillation auriculaire non valvulaire après une hospitalisation pour surdosage en anticoagulants. Rev Med Interne 2017. [DOI: 10.1016/j.revmed.2017.10.392] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
43
|
Serfaty A, Baron S, Crenn-Hebert C, Barry Y, Tala S. Périnatalité et bases de données médico-administratives : quels usages, quels acteurs, quels enjeux pour les données sur les naissances ? – Spécial REDSIAM. Rev Epidemiol Sante Publique 2017; 65 Suppl 4:S209-S219. [DOI: 10.1016/j.respe.2017.06.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/09/2017] [Revised: 06/15/2017] [Accepted: 06/22/2017] [Indexed: 11/17/2022] Open
|
44
|
Le Gall J, Nizon M, Pichon O, Andrieux J, Audebert-Bellanger S, Baron S, Beneteau C, Bilan F, Boute O, Busa T, Cormier-Daire V, Ferec C, Fradin M, Gilbert-Dussardier B, Jaillard S, Jønch A, Martin-Coignard D, Mercier S, Moutton S, Rooryck C, Schaefer E, Vincent M, Sanlaville D, Le Caignec C, Jacquemont S, David A, Isidor B. Sex chromosome aneuploidies and copy-number variants: a further explanation for neurodevelopmental prognosis variability? Eur J Hum Genet 2017; 25:930-934. [PMID: 28612834 DOI: 10.1038/ejhg.2017.93] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/30/2016] [Revised: 04/28/2017] [Accepted: 05/03/2017] [Indexed: 01/19/2023] Open
Abstract
Sex chromosome aneuploidies (SCA) is a group of conditions in which individuals have an abnormal number of sex chromosomes. SCA, such as Klinefelter's syndrome, XYY syndrome, and Triple X syndrome are associated with a large range of neurological outcome. Another genetic event such as another cytogenetic abnormality may explain a part of this variable expressivity. In this study, we have recruited fourteen patients with intellectual disability or developmental delay carrying SCA associated with a copy-number variant (CNV). In our cohort (four patients 47,XXY, four patients 47,XXX, and six patients 47,XYY), seven patients were carrying a pathogenic CNV, two a likely pathogenic CNV and five a variant of uncertain significance. Our analysis suggests that CNV might be considered as an additional independent genetic factor for intellectual disability and developmental delay for patients with SCA and neurodevelopmental disorder.
Collapse
Affiliation(s)
| | - Mathilde Nizon
- Service de Génétique Médicale, CHU Nantes, Nantes, France
| | | | - Joris Andrieux
- Laboratoire de Génétique Médicale, CHRU Lille, Lille, France
| | | | - Sabine Baron
- Service d'endocrinologie Pédiatrique, CHU Nantes, Nantes, France
| | | | - Frédéric Bilan
- Service de Génétique, CHU Poitiers, France; EA 3808 Université Poitiers, France
| | - Odile Boute
- Génétique Médicale, CHRU Lille, Lille, France
| | - Tiffany Busa
- Génétique Médicale, CHU Timone Enfants, AP-HM, Marseille, France
| | | | - Claude Ferec
- Laboratoire de Génétique Moléculaire et d'histocompatibilité, CHU Brest, Brest, France
| | | | | | | | - Aia Jønch
- Service de Génétique Médicale, CHU Vaudois, Lausanne, Switzerland
| | | | - Sandra Mercier
- Service de Génétique Médicale, CHU Nantes, Nantes, France
| | | | | | - Elise Schaefer
- Service de Génétique Médicale, CHU Strasbourg, Strasbourg, France
| | - Marie Vincent
- Service de Génétique Médicale, CHU Nantes, Nantes, France
| | | | | | | | - Albert David
- Service de Génétique Médicale, CHU Nantes, Nantes, France
| | | |
Collapse
|
45
|
Affiliation(s)
- E. L. Wachspress
- Knolls Atomic Power Laboratory, General Electric Company for the U. S. Atomic Energy Commission, Schenectady, New York
| | - R. D. Burgess
- Knolls Atomic Power Laboratory, General Electric Company for the U. S. Atomic Energy Commission, Schenectady, New York
| | - S. Baron
- Knolls Atomic Power Laboratory, General Electric Company for the U. S. Atomic Energy Commission, Schenectady, New York
| |
Collapse
|
46
|
Criquet A, Mai E, Saucourt C, Vogt S, Giganti P, Baron S, Roncalli J, Lairez O, Lagente C, Lebrin M, Ioannides K, Manrique A, Saloux E, Leroux L, Goin V, Roubille F, Lefèvre T, Hovasse T, Vanzetto G, Derenne S, Tertrais K, Newby D, Cruden N, Mills N, Greenwood J, Wheatcroft S, Dickinson A, Black A, Henon P. Challenges between clinical sites and cell therapy facilities in the excellent trial (expanded cell endocardiac transplantation), a phase I/IIb clinical trial. Cytotherapy 2017. [DOI: 10.1016/j.jcyt.2017.02.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
47
|
Mahamat Nadjib A, Attoh-Touré H, Baron S, Abdel-mahamoud A, Brunet-Houdard S, Rusch E, Grammatico-Guillon L. Connaissances, attitudes et pratiques des parents face à la vaccination contre la poliomyélite à Abéché, Tchad. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.03.110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022] Open
|
48
|
Beddag M, Sedki K, Duclos C, Baron S, Tsopra R. Mieux comprendre les comptes rendus d’hospitalisation pour mieux les coder. Un exemple en cardiologie. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.01.068] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
49
|
Joa F, Baron S, Jany B, Müller J, Langen H, Held M. Schwere Hypoxämie, restriktive Ventilationsstörung und pulmonale Infiltrate bei Morbus Niemann-Pick. Pneumologie 2017. [DOI: 10.1055/s-0037-1598396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- F Joa
- Abteilung Innere Medizin Pneumologie, Klinikum Würzburg Mitte gGmbH
| | - S Baron
- Abteilung Innere Medizin Pneumologie, Klinikum Würzburg Mitte gGmbH
| | - B Jany
- Abteilung Innere Medizin Pneumologie, Klinikum Würzburg Mitte gGmbH
| | - J Müller
- Pathologisches Institut der Universität Würzburg
| | - H Langen
- Abteilung für Radiologie, Klinikum Würzburg Mitte gGmbH
| | - M Held
- Abteilung Innere Medizin Pneumologie, Klinikum Würzburg Mitte gGmbH
| |
Collapse
|
50
|
Diehl P, Tedesco D, Makhanov M, Baron S, Suchkov D, Frangou C, Chenchik A. CRISPR/Cas9 genome-wide gRNA library for target identification. Eur J Cancer 2016. [DOI: 10.1016/s0959-8049(16)32714-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|